{"study_id": 42904, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-arthritic potential of lupeol compared to indomethacin in a collagen-induced arthritis (CIA) rat model.", "results_summary": "Lupeol significantly reduced inflammatory markers, cytokines, paw volume, and histological changes while enhancing apoptosis. It also reverted hematological and biochemical alterations associated with arthritis, suggesting anti-inflammatory and apoptotic effects.", "population_specificity": "Collagen-induced arthritis (CIA) rats", "effective_dosage": "10 mg/kg body weight (lupeol), 3 mg/kg body weight (indomethacin)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:03.864586+00:00"}
{"study_id": 42906, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of intra-articular hyaluronic acid (IA-HA) and oral NSAIDs on urinary CTX-II levels in knee osteoarthritis patients to understand their differing modes of action.", "results_summary": "IA-HA increased urinary CTX-II levels, while NSAIDs reduced them, suggesting distinct mechanisms of symptom improvement in knee osteoarthritis. The between-group difference in CTX-II changes was statistically significant.", "population_specificity": "200 knee osteoarthritis patients from 20 hospitals.", "effective_dosage": "IA-HA (2,700 kDa, 5 injections at 1-week intervals) or NSAID (loxoprofen sodium, 180 mg/day).", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:07.099165+00:00"}
{"study_id": 42894, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to extract and characterize Type-II Collagen from blue shark cartilage and assess its biochemical properties for potential biomedical applications.", "results_summary": "The study successfully isolated Type-II Collagen from blue shark cartilage, confirming its structural integrity, high purity, and typical collagen properties, including fibrous microstructure, amino acid composition, and thermal stability.", "population_specificity": "Not applicable (in vitro study on extracted collagen).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:08.191997+00:00"}
{"study_id": 42909, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immunomodulatory and therapeutic effects of oral undenatured type II collagen on osteoarthritis, focusing on pain reduction, functional improvement, and joint protection.", "results_summary": "The study found that oral undenatured type II collagen significantly reduced pain, improved musculoskeletal function, and may offer protection against joint damage from mechanical stress in both affected and healthy joints. The mechanism involves systemic tolerance, inhibition of proinflammatory processes, and enhancement of anti-inflammatory effects.", "population_specificity": "Patients with osteoarthritis (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:10.789266+00:00"}
{"study_id": 42907, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and evaluate type II collagen (CII)-containing scaffolds combined with hyaluronic acid (HyA) to enhance cartilage repair by improving MSC chondrogenesis and cartilage-like matrix formation.", "results_summary": "The CII-containing scaffolds, especially when combined with HyA, showed enhanced deposition and distribution of sulphated glycosaminoglycans (sGAG) by day 28, indicating improved chondrogenic benefits compared to traditional type I collagen scaffolds. The scaffolds exhibited high porosity (99%) and mechanical properties similar to optimized collagen-based scaffolds.", "population_specificity": "Mesenchymal stem cells (MSCs) in vitro (cartilage tissue engineering context).", "effective_dosage": "Not specified", "study_duration": "28 days (in vitro)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:11.068564+00:00"}
{"study_id": 42908, "supplement_id": 1640, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of resveratrol monotherapy on serum levels of type II collagen (Coll 2-1) and aggrecan in patients with knee osteoarthritis.", "results_summary": "Resveratrol administration led to a nonsignificant decrease in Coll 2-1 serum levels but a significant increase in aggrecan. It also significantly improved pain scores (VAS and KOOS) and functional status after 30 days, with sustained benefits over three months.", "population_specificity": "Patients with knee osteoarthritis.", "effective_dosage": "500 mg/day in a single oral dose.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:11.390862+00:00"}
{"study_id": 42911, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether modifying mesenchymal stem cells (MSCs) with palmitated protein G (PPG) and type II collagen antibody could enhance targeted delivery and engraftment for cartilage repair.", "results_summary": "The study found that PPG-modified MSCs successfully conjugated with type II collagen antibody without affecting cell proliferation or differentiation. The antibody-conjugated MSCs showed improved attachment to osteochondral surfaces, suggesting potential for targeted therapy in cartilage defects.", "population_specificity": "Bone marrow-derived mesenchymal stem cells (MSCs) in vitro and in osteochondral defect explants.", "effective_dosage": "Not specified", "study_duration": "Attachment assessed within 48 hours; other durations not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:12.959057+00:00"}
{"study_id": 42912, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and validate a specific assay for measuring type II collagen degradation (T2CM) and assess its potential as a noninvasive biomarker for osteoarthritis (OA).", "results_summary": "The T2CM assay was technically robust and specific for type II collagen fragments cleaved by MMP-1 and -13. Elevated T2CM levels were found in end-stage OA patients, and salmon calcitonin treatment reduced T2CM levels compared to placebo.", "population_specificity": "OA patients (end-stage and moderate) and those receiving salmon calcitonin treatment.", "effective_dosage": "Not specified", "study_duration": "Up to 24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:13.962360+00:00"}
{"study_id": 42910, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory and therapeutic effects of tomatidine (Td) on TNF\u03b1-induced arthritic fibroblast-like synoviocytes (FLSs) and collagen-induced arthritis (CIA) in rats.", "results_summary": "Td significantly inhibited TNF\u03b1-induced proliferation and migration of arthritic FLSs, ameliorated synovial inflammation and joint destruction in CIA rats, and suppressed pro-inflammatory cytokines (IL-1\u03b2, IL-6, TNF\u03b1) and downregulated MMP-9 and RANKL expression. The effects were linked to decreased activation of MAPKs (ERK, JNK) and NF-\u03baB.", "population_specificity": "Rats with collagen-induced arthritis (CIA) and TNF\u03b1-induced arthritic fibroblast-like synoviocytes (FLSs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:14.003622+00:00"}
{"study_id": 42914, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vorinostat could protect against IL-1\u03b1-induced reduction of type II collagen in osteoarthritis.", "results_summary": "Vorinostat prevented IL-1\u03b1-induced reduction of type II collagen at gene and protein levels, reduced mitochondrial ROS production, and inhibited MMP-13 and ELF3 expression, which are involved in collagen degradation.", "population_specificity": "T/C-28a2 cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:16.968206+00:00"}
{"study_id": 42913, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of Q-1, a coumarin derivative, in regulating rheumatoid arthritis (RA) via the NF-\u03baB signaling pathway using a bovine type II collagen-induced arthritis (CIA) rat model.", "results_summary": "Q-1 significantly reduced arthritis indices, ankle joint swelling, inflammatory cytokine levels (IL-1\u03b2, IL-6, MCP-1), and NF-\u03baB pathway proteins (I\u03baB, P-I\u03baB, P65, P-P65) in CIA rats, demonstrating anti-inflammatory and RA-inhibiting effects.", "population_specificity": "Bovine type II collagen-induced arthritis (CIA) rat model.", "effective_dosage": "High dose (30 mg\u00b7kg\u207b\u00b9) and low dose (15 mg\u00b7kg\u207b\u00b9), administered intragastrically.", "study_duration": "28 consecutive days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:18.230450+00:00"}
{"study_id": 42916, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Telmisartan could mitigate TNF-\u03b1-induced degradation of type II collagen in chondrocytes and its potential role in treating osteoarthritis.", "results_summary": "Telmisartan reduced TNF-\u03b1-induced oxidative stress and proinflammatory mediators, restored type II collagen levels, and acted mechanistically by restoring SOX-9 expression, suggesting its potential as an OA treatment.", "population_specificity": "Human C28/I2 chondrocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:19.538532+00:00"}
{"study_id": 42915, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether marine-derived Type-II Collagen (SCII) could accelerate fracture healing by regulating muscle paracrine factors and activating specific signaling pathways.", "results_summary": "SCII significantly reduced TNF-\u03b1 and increased aggrecan levels by day 5, accelerated chondrocyte proliferation and mineralization by day 10, and elevated key growth factors (IGF-1, irisin) and bone formation markers (Wnt10b, \u03b2-catenin, Runx2) through the Ihh/PThrp and Wnt/\u03b2-catenin pathways.", "population_specificity": "Mice with induced tibial fractures.", "effective_dosage": "Not specified.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:20.442565+00:00"}
{"study_id": 42918, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CII-specific ACAID B cells could induce immune tolerance in mice, potentially offering therapeutic benefits for CII-mediated autoimmune diseases.", "results_summary": "The study found that adoptive transfer of CII-specific ACAID B cells significantly suppressed immune responses in mice challenged with CII, demonstrating immune tolerance across three different mouse strains (C57BL/6, BALB/c, and DBA/1).", "population_specificity": "Mice (C57BL/6, BALB/c, and DBA/1 strains)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:21.061505+00:00"}
{"study_id": 42920, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to confirm the preventive and therapeutic effects of undenatured type II collagen (UC II) on osteoarthritis in aging db/db mice and patients with type 2 diabetes mellitus.", "results_summary": "UC II significantly improved motor functions, reduced inflammatory and oxidative stress markers, and enhanced physical activity in both mice and human subjects. Pain, stiffness, and physical function scores decreased, while mobility metrics improved.", "population_specificity": "Aging db/db mice and 55 T2DM patients diagnosed with knee osteoarthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:23.615582+00:00"}
{"study_id": 42921, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to test the effects of undenatured type II collagen (UC-II) on joint inflammation and pain in a monoiodoacetate (MIA)-induced osteoarthritis (OA) model and investigate potential mechanisms.", "results_summary": "UC-II reduced MIA-induced joint damage (53.3%), lowered inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1, COMP, CRP), inhibited cartilage degradation markers (PGE2, COX-2, NF-\u03baB, MMP-3), and increased protective factors (COL-1, OPG).", "population_specificity": "Female Wistar rats with MIA-induced osteoarthritis.", "effective_dosage": "4 mg/kg body weight.", "study_duration": "Seven days of UC-II treatment before MIA induction.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:25.477469+00:00"}
{"study_id": 42922, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-arthritic effects of SC-E3, a polyherbal formula, in a mouse model of type-II collagen-induced arthritis (CIA).", "results_summary": "SC-E3 demonstrated anti-arthritic effects by reducing paw swelling, bone erosion, inflammatory cell infiltration, and pro-inflammatory cytokines in CIA mice. It also inhibited osteoclastogenesis in bone marrow-derived macrophages.", "population_specificity": "Male DBA/1J mice with type-II collagen-induced arthritis.", "effective_dosage": "Not specified (daily oral administration).", "study_duration": "23 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:25.827423+00:00"}
{"study_id": 42919, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of dextrose prolotherapy versus hyaluronic acid injections on urinary C-terminal telopeptide of type II collagen levels and pain scores in knee osteoarthritis patients.", "results_summary": "Dextrose prolotherapy significantly reduced urinary C-terminal telopeptide of type II collagen levels and pain scores compared to hyaluronic acid, but neither treatment affected serum cartilage oligomeric proteinase levels.", "population_specificity": "Patients with knee osteoarthritis (47 participants: 21 hyaluronic acid, 26 dextrose prolotherapy).", "effective_dosage": "Dextrose prolotherapy group received 3 injections (weeks 1, 5, and 9); hyaluronic acid group received 5 injections (weeks 1-5).", "study_duration": "Follow-up measurements were taken 3 weeks after the last injection (total duration varied by group: ~12 weeks for dextrose prolotherapy, ~8 weeks for hyaluronic acid).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:27.137889+00:00"}
{"study_id": 42924, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to identify potential biomarkers, including type II collagen cleavage neoepitope (C2C), to detect early-stage musculoskeletal changes in brucellosis patients.", "results_summary": "The study found significantly elevated serum levels of C2C in early-stage male brucellosis patients compared to controls, suggesting its potential as a biomarker for osteoarticular changes in brucellosis.", "population_specificity": "41 male early-stage brucellosis patients (within 6 months of diagnosis) and 44 matched controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:27.924512+00:00"}
{"study_id": 42923, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the anti-rheumatoid arthritis (RA) effect and mechanism of ethyl acetate extract of Rhamnella gilgitica (RGEA) on collagen-induced arthritis (CIA) in rats.", "results_summary": "RGEA treatment restored body weight, reduced arthritis index and paw swelling, decreased inflammatory cytokines (IL-1\u03b2, IL-6, IL-17, TNF-\u03b1, INF-\u03b3), increased anti-inflammatory cytokines (IL-4, IL-10), promoted synovial cell apoptosis, and modulated the JAK-STAT pathway.", "population_specificity": "Male Wistar rats with collagen-induced arthritis.", "effective_dosage": "9.71, 19.43, or 38.85 mg/kg orally administered.", "study_duration": "23 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:28.266951+00:00"}
{"study_id": 42925, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop and evaluate synthetic triple helical peptides (THPs) from Type-II Collagen for detecting autoantibodies in rheumatoid arthritis (RA) patients to aid in early diagnosis and treatment selection.", "results_summary": "The study found that synthetic THPs effectively detected autoantibodies in RA patients, with increased antibody levels against specific CII epitopes compared to controls, highlighting the importance of triple-helical conformation for epitope recognition.", "population_specificity": "Patients with rheumatoid arthritis and control individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:28.957479+00:00"}
{"study_id": 42926, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of GPR17 in TNF-\u03b1-induced reduction of type II collagen and explore pranlukast's potential to protect type II collagen degradation in osteoarthritis.", "results_summary": "The study found that pranlukast, a GPR17 antagonist, prevented TNF-\u03b1-induced reduction of type II collagen and suppressed MMP-3 and MMP-13 expression, which degrade collagen. It also inhibited oxidative stress and pro-inflammatory pathways, suggesting GPR17 as a potential therapeutic target for osteoarthritis.", "population_specificity": "ATDC5 cells (a chondrogenic cell line) exposed to TNF-\u03b1.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:30.431712+00:00"}
{"study_id": 42928, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a sensitive detection method for uCTX-II, a biomarker for osteoarthritis, using antibody-conjugated gold nanoparticles on an interdigitated electrode.", "results_summary": "The study successfully developed a detection strategy with a sensitivity of 10 pM and a linear response to increasing uCTX-II concentrations, confirming specific detection without interference from controls.", "population_specificity": "Not specified (focus was on methodological development).", "effective_dosage": "Not applicable (methodological study).", "study_duration": "Not applicable (methodological study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:34.297258+00:00"}
{"study_id": 42929, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of the GPR40 agonist GW9508 on protecting Type-II Collagen and aggrecan from degradation in AGEs-treated chondrocytes.", "results_summary": "GW9508 protected Type-II Collagen and aggrecan by reducing the expression of degrading enzymes (MMP-3, MMP-13, ADAMTS-4, ADAMTS-5) and pro-inflammatory cytokines, while suppressing NF-\u03baB activation in AGEs-induced chondrocytes. These effects were mediated by GPR40, as co-treatment with antagonist GW1100 abolished the benefits.", "population_specificity": "Human SW1353 chondrocytes (in vitro study)", "effective_dosage": "100 \u00b5g/mL AGEs (GW9508 dosage not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.226225+00:00"}
{"study_id": 42932, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the regenerative potential of demineralized bone matrix with a collagen membrane (GTR) versus eggshell components (including its type X collagen membrane) in periodontal defects.", "results_summary": "Both treatments showed intensive new bone formation, complete defect healing, and resolved inflammation with no significant differences between them, though the test group (eggshell components) had more connective tissue.", "population_specificity": "Wistar rats with induced periodontal defects.", "effective_dosage": "Not specified", "study_duration": "45 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.507429+00:00"}
{"study_id": 42933, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of decitabine (DAC) on a murine model of rheumatoid arthritis induced by Type-II Collagen.", "results_summary": "DAC administration significantly improved clinical conditions in mice, reducing Th1 and Th17 pro-inflammatory cytokines and lowering anti-Type-II Collagen autoantibodies. The study demonstrated beneficial immunological modifications in treated mice.", "population_specificity": "Murine model (mice) with rheumatoid arthritis induced by Type-II Collagen.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.821573+00:00"}
{"study_id": 42931, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between urinary C-Telopeptide fragments of type II collagen (uCTX-II) and knee joint moments, pain, and physical function in individuals with medial knee osteoarthritis (OA).", "results_summary": "The study found no relationship between uCTX-II levels and knee moments but reported significant correlations between uCTX-II levels and pain, physical function, and 40m walk test performance. uCTX-II levels explained 9% of pain scores, 27% of physical function scores, and 7% of walk test performance.", "population_specificity": "25 subjects radiographically diagnosed with medial knee OA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.962434+00:00"}
{"study_id": 42930, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether blocking the SDF-1/CXCR4 signaling pathway with three antagonists (TN14003, T140, AMD3100) could delay articular cartilage degeneration by reducing MMP expression and preserving Type-II Collagen and aggrecan.", "results_summary": "The study found that all three antagonists reduced SDF-1 levels and MMP expression while increasing Type-II Collagen and aggrecan mRNA levels, with TN14003 showing the strongest effect in delaying cartilage degeneration.", "population_specificity": "Male Duncan-Hartley guinea pigs (6 months old)", "effective_dosage": "180 \u03bcg/ml daily for each antagonist (TN14003, T140, AMD3100)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:38.521935+00:00"}
{"study_id": 42934, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between Type-II collagen cleavage products (CTX-II) and structural joint damage in knee osteoarthritis (OA).", "results_summary": "The study found that higher levels of CTX-II correlated with increased MRI-detected joint damage (e.g., cartilage degradation, bone marrow lesions, and synovitis), suggesting CTX-II as a biomarker for OA severity. However, the study did not assess the direct therapeutic effects of Type-II collagen supplementation.", "population_specificity": "Adults with mild or advanced knee osteoarthritis and non-OA controls.", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:40.614467+00:00"}
{"study_id": 42935, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the pharmacological mechanisms of Guizhi-Shaoyao-Zhimu (GSZD) in treating Type II collagen-induced arthritis (CIA) in rats and its effects on synovial fibroblasts.", "results_summary": "GSZD reduced toe swelling, arthritis scores, and inflammatory cytokines in CIA rats, improved joint pathology, and exhibited anti-proliferative, pro-apoptotic, and anti-invasive effects on synovial fibroblasts. It also modulated apoptosis-related gene expressions.", "population_specificity": "Type II collagen-induced arthritis (CIA) rat model and TNF-\u03b1 stimulated MH7A cells (human synovial fibroblasts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:43.115849+00:00"}
{"study_id": 42936, "supplement_id": 1640, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the persistence, biodistribution, and genomic integration risk of the DNA vaccine pcDNA-CCOL2A1 encoding chicken type II collagen (CCII) for rheumatoid arthritis treatment.", "results_summary": "The study found that CCOL2A1 mRNA and CCII protein were rapidly cleared, with no genomic integration, and expression was transient in specific tissues, supporting its safety profile for RA treatment.", "population_specificity": "Normal vaccinated rodents.", "effective_dosage": "300 \u03bcg/kg via intramuscular injection (single dose).", "study_duration": "Up to 42 days post-immunization.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:45.322639+00:00"}
{"study_id": 42938, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanistic effects of glycyrrhizin (GL) and/or platelet-rich plasma (PRP) treatment on collagen-induced arthritis in rats.", "results_summary": "The study found that combined treatment with GL and PRP significantly improved inflammation and autophagy biomarkers, reduced HMGB-1 and beclin-1 levels, downregulated LC3 mRNA expression, and restored antioxidant status by inhibiting MPO activity and inducing catalase and Nrf2-DNA binding activities.", "population_specificity": "Female Wistar rats with collagen-induced arthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:45.733991+00:00"}
{"study_id": 42939, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lunasin could mitigate cartilage degradation by suppressing MMPs and preserving type II collagen in the context of osteoarthritis.", "results_summary": "Lunasin suppressed MMP-3 and MMP-13 increases, prevented TIMP-1 and TIMP-2 reductions, and attenuated type II collagen loss, suggesting potential chondro-protective effects. It also inhibited the JAK2/STAT1/IRF-1 pathway.", "population_specificity": "Not specified (likely in vitro or animal model based on abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:46.269437+00:00"}
{"study_id": 42940, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether saxagliptin, a DPP-4 inhibitor, could protect Type-II collagen from degradation by reducing the expression of cartilage-degrading enzymes in human chondrocytes.", "results_summary": "Saxagliptin significantly decreased the expression of MMP-1, MMP-3, MMP-13, ADAMTS-4, and ADAMTS-5, preventing Type-II collagen and aggrecan degradation. It also reduced oxidative stress and acted through the p38/I\u03baB\u03b1/NF-\u03baB pathway.", "population_specificity": "Primary human chondrocytes.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:47.257633+00:00"}
{"study_id": 42937, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of undenatured type II collagen (UC-II) and robenacoxib on improving mobility in dogs with osteoarthritis.", "results_summary": "UC-II and robenacoxib showed similar efficacy in reducing LOAD and MOBILITY scores, with UC-II achieving a 32.7% improvement (p = 0.013). Both treatments significantly improved mobility in dogs with osteoarthritis.", "population_specificity": "Client-owned dogs affected by osteoarthritis.", "effective_dosage": "UC-II 1 tablet/day.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:48.108054+00:00"}
{"study_id": 42941, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to isolate immunomodulatory peptides from Type-II Collagen (CII) in chick sternal cartilage using a novel CIEH-MS system and evaluate their potential applications.", "results_summary": "The CIEH-MS system effectively isolated immunomodulatory peptides with high lymphocyte proliferation activity (85.54%) and binding ability to HLA-DRB1 molecules (133.2 ng/ml), demonstrating potential for functional foods and medical applications.", "population_specificity": "Chick sternal cartilage (in vitro study, no human or animal subjects specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:49.286577+00:00"}
{"study_id": 42927, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of integrin \u03b12\u03b21 in T-2 toxin-induced chondrocyte damage and its impact on type II collagen production.", "results_summary": "The study found that T-2 toxin reduced type II collagen production and increased MMP-13 levels in chondrocytes, but integrin \u03b12\u03b21 inhibitor blocked matrix degradation.", "population_specificity": "Sprague-Dawley rats and C28/I2 chondrocytes", "effective_dosage": "100 ng/g BW/day (in vivo); 0, 6, 12, and 24 ng/mL (in vitro)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:51.308453+00:00"}
{"study_id": 42942, "supplement_id": 1640, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify biomarkers of efficacy for intra-articular hyaluronic acid (HYMOVIS\u00ae) in knee osteoarthritis and assess its potential disease-modifying effects.", "results_summary": "The study found increased type II collagen turnover (Coll2-1 and PIIANP levels), improved cartilage volume in lateral knee compartments, reduced synovitis, and enhanced KOOS scores, suggesting positive structural and symptomatic effects.", "population_specificity": "46 patients with symptomatic knee osteoarthritis.", "effective_dosage": "Two treatment cycles of intra-articular HYMOVIS\u00ae (8 mg/mL, 3 mL per injection), each cycle involving two injections 1 week apart, repeated at 6-month intervals.", "study_duration": "1 year (with follow-up at baseline and 1 year).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:53.898934+00:00"}
{"study_id": 42945, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the diagnostic value of 68Ga-citrate and 18F-FDG PET/CT in detecting type II collagen-induced arthritis (CIA) in rats.", "results_summary": "68Ga-citrate PET/CT was significantly superior to 18F-FDG PET/CT for imaging CIA, showing earlier and more sensitive detection of inflammatory activity in affected joints, with this advantage persisting into later stages of inflammation.", "population_specificity": "Rats with type II collagen-induced arthritis (CIA).", "effective_dosage": "Not specified.", "study_duration": "Evaluated at 23 days (early) and 40 days (late) post-induction.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:55.294870+00:00"}
{"study_id": 42943, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of paeonol in inhibiting factors related to osteoarthritis, including the degradation of type II collagen.", "results_summary": "Paeonol demonstrated the ability to inhibit multiple OA-related factors, including IL-6, TNF-\u03b1, NOX2, PTGS2, NUCB2/nesfatin-1, ICAM-1, VCAM-1, MMP-3/13, and degradation of type II collagen, while also suppressing NF-\u03baB activation. Cell viability tests confirmed its safety.", "population_specificity": "Chondrogenic cell line ATDC5 cells cultured with IL-1\u03b2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:55.296197+00:00"}
{"study_id": 42944, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether activation of TGR5 using INT-777 could protect against TNF-\u03b1-induced degradation of type II collagen and other ECM components in chondrocytes.", "results_summary": "Activation of TGR5 with INT-777 reduced TNF-\u03b1-induced degradation of type II collagen and aggrecan by inhibiting MMP-3, MMP-13, ADAMTS-4, and ADAMTS-5 expression, and suppressed the IKK/I\u03baB\u03b1/NF-\u03baB signaling pathway. Knockdown of TGR5 abolished these protective effects, confirming its involvement.", "population_specificity": "Human primary chondrocytes and human chondrosarcoma SW1353 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:55.778317+00:00"}
{"study_id": 42947, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of salicin on AGE-induced degradation of type II collagen and aggrecan in human chondrocytes, as well as its potential to reduce oxidative stress and inflammation.", "results_summary": "Salicin demonstrated a beneficial role in rescuing degradation of type II collagen and aggrecan, reducing oxidative stress, attenuating proinflammatory cytokines, and inhibiting the NF-\u03baB pathway in AGE-stimulated chondrocytes.", "population_specificity": "SW1353 human chondrocytes (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:56.415562+00:00"}
{"study_id": 42946, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the feasibility and molecular mechanism of IL-10-modified BMSCs in treating CIA rats induced by Type-II Collagen.", "results_summary": "IL-10-modified BMSCs significantly improved body weight, reduced ankle swelling, enhanced forced swimming time, promoted cartilage repair, and suppressed synovial proliferation compared to untreated or BMSCs-only groups. Serum levels of inflammatory cytokines (IL-17, IL-1\u00df, TNF-alpha) were lower, and SIRT1 protein levels in peripheral blood mononuclear cells and spleen were modulated.", "population_specificity": "CIA (collagen-induced arthritis) rat model.", "effective_dosage": "Not specified.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:56.748043+00:00"}
{"study_id": 42948, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of Saururus chinensis leaf water extract (SHW) on type II collagen-induced arthritis (CIA) in mice.", "results_summary": "SHW (500 mg/kg) reduced serum levels of IL-6, TNF-alpha, and collagen IgG, decreased hind limb swelling, and reduced monocyte infiltration in CIA mice. The results suggest SHW may mitigate arthritis symptoms by lowering inflammatory markers.", "population_specificity": "Type II collagen-induced arthritis (CIA) mouse models.", "effective_dosage": "100 mg/kg and 500 mg/kg SHW, orally administered.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:58.056408+00:00"}
{"study_id": 42949, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether type II collagen extract could enhance immune responses in rats with deteriorated immunity caused by methotrexate.", "results_summary": "Type II collagen extract significantly increased body weight, total blood leukocyte numbers, total lymphocyte numbers in the spleen, and the ratio of CD4+ and CD8+ T-cells in both blood and spleen compared to the control group. The results suggest that type II collagen extract can improve immune function in rats with methotrexate-induced immune deterioration.", "population_specificity": "SD rats with methotrexate-induced deteriorated immunity.", "effective_dosage": "250 mg/kg and 500 mg/kg, administered once daily via gastric gavage.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:01.399212+00:00"}
{"study_id": 42950, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-rheumatoid arthritis effects of Anoectochilus roxburghii polysaccharides (ARP) using a rat model of type II collagen-induced arthritis (CIA).", "results_summary": "ARP significantly reduced arthritis symptoms, decreased inflammatory cell infiltration, and inhibited synovial tissue destruction in CIA rats. It also suppressed the NF-\u03baB pathway, down-regulated IL-1\u03b2 and IL-6 mRNA expressions, and exhibited antioxidant activity.", "population_specificity": "Rats with type II collagen-induced arthritis (CIA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:02.776459+00:00"}
{"study_id": 42951, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether estradiol (E2) protects against intervertebral disc degeneration (IVDD) by modulating Type-II Collagen expression in a rat model.", "results_summary": "E2 reversed IVDD by decreasing caspase-3, MMP-3, and MMP-13 expression while increasing Type-II Collagen expression, effects blocked by estrogen receptor inhibition.", "population_specificity": "Three-month-old female Sprague Dawley rats.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:03.247913+00:00"}
{"study_id": 42953, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether type II collagen stimulates nucleus pulposus-like differentiation of adipose-derived stem cells (ADSCs) and the role of FoxA2 in this process.", "results_summary": "Type II collagen promoted NP-like differentiation of ADSCs by increasing FoxA2 expression, and FoxA2 overexpression enhanced NP-specific gene expression and extracellular matrix synthesis. FoxA2-overexpressing ADSCs combined with type II collagen hydrogels improved regeneration of degenerated NP in vivo.", "population_specificity": "Adipose-derived stem cells (ADSCs) and in vivo models of intervertebral disc degeneration.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:04.846195+00:00"}
{"study_id": 42952, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of glucosamine methyl ester on cartilage degeneration, including Type-II Collagen levels, in an osteoarthritis rat model.", "results_summary": "Glucosamine methyl ester significantly reduced cartilage degeneration, increased Type-II Collagen levels, and inhibited inflammatory markers like interleukin-1\u03b2 and matrix metalloproteinases. The highest dose (10 mg/kg) showed the most pronounced effects, with Type-II Collagen levels increasing ~3.6-fold compared to untreated rats.", "population_specificity": "Sprague-Dawley rats with induced osteoarthritis", "effective_dosage": "2, 5, and 10 mg/kg daily", "study_duration": "One month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:04.993421+00:00"}
{"study_id": 42954, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether gemigliptin could inhibit IL-1\u03b2-induced degradation of type II collagen in human chondrocytes and its potential as a therapeutic strategy for osteoarthritis.", "results_summary": "Gemigliptin inhibited the expression of MMP-1, MMP-3, and MMP-13 at gene and protein levels, suppressed NF-\u03baB signaling pathway activation, and reduced phosphorylation of IKK/I\u03baB\u03b1 and p38, suggesting chondroprotective effects.", "population_specificity": "Human chondrocytes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:05.053198+00:00"}
{"study_id": 42956, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sodium butyrate influences IL-1\u03b2-induced degradation of type II collagen in human chondrocytes in the articular cartilage matrix.", "results_summary": "Sodium butyrate significantly reduced IL-1\u03b2-induced up-regulation of MMP-1, MMP-3, and MMP-13, suppressed TIMP-1 and TIMP-2 expression, and attenuated type II collagen degradation by inhibiting NF-\u03baB activation.", "population_specificity": "Human chondrocytes from patients with osteoarthritis (OA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:06.539513+00:00"}
{"study_id": 42958, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory and anti-arthritic effects of crocin on type II collagen-induced arthritis (CIA) in Wistar rats.", "results_summary": "Crocin mitigated RA symptoms in CIA rats, including reducing arthritis scores, paw swelling, joint inflammation, and pro-inflammatory cytokine expression. The highest dose (40 mg/kg) restored histological scores and MMP levels to near-normal levels.", "population_specificity": "Wistar rats with type II collagen-induced arthritis.", "effective_dosage": "10, 20, or 40 mg/kg crocin.", "study_duration": "36 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:11.244710+00:00"}
{"study_id": 42957, "supplement_id": 1640, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a Type-II Collagen/chondroitin sulfate composite hydrogel (CCSA) as a delivery system for adipose-derived stem cells (ADSCs) to regenerate degenerated nucleus pulposus (NP) tissue.", "results_summary": "The CCSA system promoted NP-specific gene expression, restored disc height, water content, and extracellular matrix synthesis, and improved the structure of degenerated NP in a rat model. The system demonstrated biocompatibility and regenerative potential with minimal invasiveness.", "population_specificity": "Rat coccygeal vertebrae degeneration model (animal study).", "effective_dosage": "0.02% genipin cross-linked CCSA (specific dosage not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:12.408784+00:00"}
{"study_id": 42960, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the motility of dental pulp stem cells (DPSCs) and DPSC-derived chondrogenic cells in type I and type II collagen hydrogels for potential disc regeneration.", "results_summary": "DPSCs showed high viability in both non-crosslinked and crosslinked collagen hydrogels. Migration speed of DPSC-derived chondrogenic cells was higher in type I collagen hydrogel than in type II, and crosslinking type I collagen reduced their migration speed.", "population_specificity": "In vitro study using dental pulp stem cells (DPSCs) and DPSC-derived chondrogenic cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:13.377118+00:00"}
{"study_id": 42955, "supplement_id": 1640, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to isolate and characterize squid-derived type II collagen (SCII), evaluate its immunogenicity compared to bovine type II collagen (BCII), and assess its anti-inflammatory and osteoarthritis-relieving effects.", "results_summary": "SCII showed no immunogenicity, reduced pro-inflammatory cytokines, prevented chondrocyte hypertrophy, impeded macrophage chemotaxis, and alleviated inflammation in OA rats.", "population_specificity": "OA rat model (in vivo) and pro-inflammatory macrophages (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:13.718371+00:00"}
{"study_id": 42962, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether SAMC could protect chondrocytes from IL-1\u03b2-induced damage and explore its potential mechanisms, including effects on Type-II collagen degradation.", "results_summary": "SAMC improved chondrocyte viability, increased Type-II collagen levels, reduced degradation products, and modulated the MMPs/TIMP-1 ratio. It also suppressed TNF-\u03b1 and NF-\u03baB signaling, suggesting a protective role in osteoarthritis.", "population_specificity": "In vitro chondrocyte model (not human subjects).", "effective_dosage": "20 and 60 \u03bcM SAMC.", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:13.784901+00:00"}
{"study_id": 42959, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if photobiomodulation therapy (PBMT) combined with adipose-derived stem/stromal cells (ADSCs) could reduce type II collagen (COL2-1) degradation and modulate inflammation in a rat model of osteoarthritis.", "results_summary": "PBMT and ADSCs upregulated COL2-1 mRNA and protein expression, reduced pro-inflammatory cytokines and MMPs, and prevented joint degeneration in the osteoarthritis model. The combination showed chondroprotective effects compared to the OA group.", "population_specificity": "Female Fischer 344 rats with induced osteoarthritis.", "effective_dosage": "10 \u00d7 10^6 ADSCs injected intra-articularly; PBMT parameters: 808 nm wavelength, 50 mW power, 42 J energy, 71.2 J/cm\u00b2 energy density, 0.028 cm\u00b2 spot size.", "study_duration": "7 days after the first treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.196989+00:00"}
{"study_id": 42963, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of combining type II collagen hydrogel, fibrin sealant, and adipose-derived stem cells (ASCs) for repairing focal articular cartilage defects in rabbit knees.", "results_summary": "The combination of type II collagen hydrogel, fibrin sealant, and ASCs promoted chondrogenic differentiation in vitro and improved cartilage repair in vivo, evidenced by increased proteoglycan production, collagen type II expression, and better tissue organization compared to treatments without ASCs.", "population_specificity": "Rabbit knees with chondral defects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.706504+00:00"}
{"study_id": 42961, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the structural requirements for recombinant chicken type II collagen (rCCII) assembly and its effectiveness in treating rheumatoid arthritis compared to native CCII (nCCII).", "results_summary": "The study found that recombinant CCII (rCCII) could assemble without C- and N-propeptides or telopeptides, and rCCII pC\u03b11(II) was as effective as nCCII in inducing collagen-induced arthritis (CIA) in a rat model. CTEs (tolerogenic epitopes) formed stable homotrimers and were secreted, while larger procollagens were retained intracellularly.", "population_specificity": "Collagen-induced arthritis (CIA) rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.957154+00:00"}
{"study_id": 42964, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a combination of PPAR-\u03b4 agonist, hBM-MSCs, and HA gel could overcome synovial inflammation and enhance the formation of type II collagen-producing chondrocytes in osteoarthritis (OA) patients.", "results_summary": "The study found that the combination of PPAR-\u03b4 agonist, hBM-MSCs, and HA gel significantly enhanced the formation of type II collagen-producing chondrocytes within OA synovial fluid, overcoming synovial inflammation, whereas individual components alone were ineffective.", "population_specificity": "Human OA synovial fluid samples from 3 different donors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:20.070901+00:00"}
{"study_id": 42965, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether undenatured native chicken type II collagen (UC-II) could prevent excessive articular cartilage deterioration in a rat model of osteoarthritis (OA).", "results_summary": "UC-II treatment preserved weight-bearing capacity, maintained cancellous bone integrity, and limited osteophyte formation and cartilage deterioration in rats with induced OA.", "population_specificity": "Male rats with surgically induced osteoarthritis via partial medial meniscectomy tear (PMMT).", "effective_dosage": "0.66 mg/kg daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:20.771940+00:00"}
{"study_id": 42969, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether IL-1\u03b2 inhibits type II collagen expression and whether curcumin can counteract this effect by inhibiting NF-\u03baB signaling.", "results_summary": "Curcumin inhibited IL-1\u03b2-induced NF-\u03baB activation, leading to downregulation of MMP-13 and upregulation of type II collagen expression, and increased chondrocyte proliferation.", "population_specificity": "Rat articular chondrocyte cell cultures", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:21.378364+00:00"}
{"study_id": 42968, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the combinatorial effect of betulinic acid and fluvastatin on atherogenesis during arthritis induced by bovine type-II collagen.", "results_summary": "The combination therapy significantly reduced arthritic index, inflammatory markers, and oxidative stress while enhancing anti-inflammatory cytokine expression, suggesting a potential reduction in rheumatoid arthritis and cardiovascular disease risk.", "population_specificity": "Arthritic patients (induced by bovine type-II collagen in the study).", "effective_dosage": "Bovine type-II collagen dissolved in 0.01M acetic acid at 4mg/mL, emulsified in incomplete Freund's adjuvant.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:22.528861+00:00"}
{"study_id": 42966, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the role of KLF2 in inhibiting cartilage matrix destruction, specifically its effects on type-II collagen degradation in chondrocytes.", "results_summary": "KLF2 overexpression inhibited IL-1\u03b2-induced MMP-13 expression and reduced type-II collagen degradation, while KLF2 knockdown exacerbated these effects, suggesting KLF2 as a potential therapeutic target for osteoarthritis.", "population_specificity": "Human chondrocytes, including primary chondrocytes and OA chondrocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:22.817834+00:00"}
{"study_id": 42967, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether low-dose halofuginone (HF) could inhibit type I collagen synthesis without affecting type II collagen in chondrocytes, potentially improving cartilage regeneration.", "results_summary": "The study found that HF inhibited type I collagen synthesis by suppressing the TGF-\u03b2 signaling pathway (via Smad2/3 phosphorylation inhibition and Smad7 promotion) while preserving type II collagen, suggesting a potential method to convert fibrocartilage into hyaline cartilage during regeneration.", "population_specificity": "Chondrocytes (in vitro study, no human or animal subjects specified).", "effective_dosage": "Low-dose HF (specific amount not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:22.949527+00:00"}
{"study_id": 42970, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Nebivolol could protect against IL-1\u03b2-induced degradation of type II collagen and MMP-13 expression in cartilage matrix.", "results_summary": "Nebivolol reversed IL-1\u03b2-induced degradation of type II collagen in a dose-dependent manner and reduced MMP-13 expression and activity by inhibiting NF-\u03baB and IRF-1 pathways.", "population_specificity": "In vitro cell culture model (specific human or animal cell type not specified).", "effective_dosage": "Dose-dependent (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:23.431050+00:00"}
{"study_id": 42971, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if type-II collagen scaffolds, with or without chondroitin sulfate, could promote chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells to potentially prevent osteoarthritis.", "results_summary": "Type-II collagen scaffolds stimulated abundant collagen type-II production, and the addition of chondroitin sulfate significantly upregulated type II collagen gene expression compared to type-I and pure type-II scaffolds. The study concluded that type-II collagen and chondroitin sulfate can promote a chondrogenic phenotype without growth factors.", "population_specificity": "Human bone marrow-derived mesenchymal stem cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:23.622870+00:00"}
{"study_id": 42973, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory effect and mechanism of action of Zaocys type II collagen on collagen-induced arthritis in mice.", "results_summary": "Zaocys type II collagen reduced arthritis scores and histological inflammation dose-dependently, increased regulatory-T cells, decreased T-helper 17 cells, and modulated cytokine levels (higher TGF-\u03b2, lower IL-17A).", "population_specificity": "C57BL/6 mice with collagen-induced arthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:28.441460+00:00"}
{"study_id": 42972, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the therapeutic effects and mechanisms of Periplocoside A (PSA) on collagen-induced arthritis (CIA) in mice, focusing on its role in regulating Th17/Treg cell balance.", "results_summary": "PSA administration significantly reduced arthritis severity, joint damage, and anti-collagen II antibody levels while modulating Th17/Treg cell balance and suppressing pro-inflammatory cytokines. The study demonstrated PSA's efficacy in alleviating CIA symptoms through immune regulation.", "population_specificity": "DBA/1 mice with collagen-induced arthritis (CIA).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:30.467672+00:00"}
{"study_id": 42975, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of oral native type II collagen combined with acetaminophen for improving symptoms and biological markers of cartilage degradation in knee osteoarthritis patients.", "results_summary": "The study found that combining type II collagen with acetaminophen significantly improved joint pain, function, and quality of life compared to acetaminophen alone, though no significant improvements were observed in biochemical markers of cartilage degradation.", "population_specificity": "Patients diagnosed with knee osteoarthritis (n=39).", "effective_dosage": "10 mg/day of native type II collagen.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:30.520978+00:00"}
{"study_id": 44134, "supplement_id": 1641, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility of reducing ultraprocessed food intake as part of a comprehensive nutritional intervention to improve metabolic and cardiovascular health in ASCVD patients.", "results_summary": "The study found significant reductions in ultraprocessed food consumption, alongside improvements in glycemic control, lipid profiles, and metabolic syndrome remission. Participants also showed enhanced adherence to healthier dietary patterns like the Mediterranean diet.", "population_specificity": "Patients with atherosclerotic cardiovascular diseases (ASCVD) and metabolic comorbidities (prediabetes or metabolic syndrome).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:31.155606+00:00"}
{"study_id": 44136, "supplement_id": 1641, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether a breastfeeding and healthy complementary feeding intervention reduced ultraprocessed food (UPF) consumption in children aged 4-7 years.", "results_summary": "The intervention reduced the risk of high UPF consumption by 35% compared to the control group, with mean UPF intake at 38% (intervention) vs. 42.7% (control). Breastfeeding duration did not affect UPF consumption.", "population_specificity": "Teenage mothers and their infants from South Brazil.", "effective_dosage": "Not specified", "study_duration": "Intervention began in the maternity ward and continued at home after delivery; follow-up at 4-7 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:32.434226+00:00"}
{"study_id": 44135, "supplement_id": 1641, "safety_score": "30", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether higher consumption of ultraprocessed foods is associated with an increased risk of chronic kidney disease (CKD).", "results_summary": "The study found that higher consumption of ultraprocessed foods was independently associated with a 24% increased risk of incident CKD, with a linear relationship observed. Substituting one serving of ultraprocessed foods with minimally processed foods reduced CKD risk by 6%.", "population_specificity": "14,679 middle-aged adults without CKD at baseline from the Atherosclerosis Risk in Communities (ARIC) study.", "effective_dosage": "Servings per day (quartiles of consumption, exact amounts not specified).", "study_duration": "Median follow-up of 24 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:32.528556+00:00"}
{"study_id": 44137, "supplement_id": 1641, "safety_score": "20", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compile evidence that ultraprocessed food, particularly added sugar, meets public health criteria for regulation (abuse, toxicity, ubiquity, and externalities) and to propose intervention strategies.", "results_summary": "The study found that ultraprocessed food, especially added sugar, is linked to non-communicable diseases (NCDs) and meets the criteria for public health regulation. Some countries have implemented sugar taxation as an intervention, but broader societal measures are needed due to food industry interference.", "population_specificity": "Global population, with a focus on Western diets.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:37.543803+00:00"}
{"study_id": 42974, "supplement_id": 1640, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between PEP-1-SIRT2 and the expression of MMP-1, MMP-13, and type II collagen in rabbit articular chondrocytes, focusing on dedifferentiation mechanisms.", "results_summary": "PEP-1-SIRT2 increased MMP-1 and MMP-13 expression, leading to decreased type II collagen levels, which was reversed by MMP inhibition or ERK pathway suppression.", "population_specificity": "Rabbit articular chondrocytes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:39.309341+00:00"}
{"study_id": 42796, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the binding effects and inhibitory activity of dietary flavone glycosides, including uridine-related compounds, on UGT enzymes, particularly UGT2B7.", "results_summary": "The study found that flavone O-glycosides like rutin had high binding affinities and inhibitory effects on UGT2B7, while flavone C-glycosides and phenolic acid metabolites showed no significant impact. In vitro experiments indicated no significant effect on UGT gene expression after 24-hour exposure.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "10 \u03bcM (for rutin, nicotifiorin, isovitexin, and other tested compounds)", "study_duration": "24 hours (in vitro exposure)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:40.202487+00:00"}
{"study_id": 44138, "supplement_id": 1641, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of a low-carbohydrate ketogenic diet as a treatment for binge eating and ultraprocessed food addiction by examining its proposed mechanisms.", "results_summary": "The study suggests that ultraprocessed, refined, or high-glycemic-index carbohydrates may trigger neurochemical responses similar to addiction, leading to overeating and hunger exacerbation. Reducing or abstaining from these foods could be an effective treatment approach, supported by recent case series.", "population_specificity": "Not specified (general focus on individuals with binge eating or ultraprocessed food addiction).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:40.956871+00:00"}
{"study_id": 42797, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether uridine supplementation could effectively treat symptoms associated with biallelic hypomorphic CAD variants, primarily focusing on hematological and developmental outcomes.", "results_summary": "The study found that uridine supplementation improved the patient's condition, including hematological abnormalities and mild developmental delay, despite functional studies not showing complete abrogation of CAD protein function. The response to uridine suggests its therapeutic potential for CAD-related disorders.", "population_specificity": "A single patient with biallelic CAD variants presenting with macrocytic anemia, elevated hemoglobin-A2 levels, anisocytosis, poikilocytosis, target cells, and mild developmental delay.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:41.170531+00:00"}
{"study_id": 42799, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of uridine-cytidine kinase 2 (Uck2) in the mutagenic activity of \u03b2-d-N4-hydroxycytidine (NHC) and its implications for ribonucleoside metabolism.", "results_summary": "The study found that inactivating Uck2 reduced NHC-induced mutagenesis, while over-expression of Uck2 enhanced it, suggesting that differences in ribonucleoside metabolism contribute to variable mutagenicity of NHC in cancer cell lines and primary tissues.", "population_specificity": "Mouse myeloid cell line and cancer cell lines.", "effective_dosage": "Not specified", "study_duration": "Short-term exposure (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:41.582097+00:00"}
{"study_id": 44133, "supplement_id": 1641, "safety_score": "30", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the relationship between ultraprocessed food (UPF) consumption and pulmonary function test results in adults with asthma.", "results_summary": "The study found that increased UPF consumption was associated with decreased % FVC expected and % FEV1/FVC values, indicating worsened respiratory function, though no significant relationship was found between UPF consumption and % FEV1 expected value.", "population_specificity": "Adults aged 18 to 65 diagnosed with asthma and receiving medical treatment (n=339).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:49.537041+00:00"}
{"study_id": 42800, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the potential drug-drug interactions (DDIs) of vericiguat, focusing on its metabolism via UGT1A9 and UGT1A1, and evaluate the impact of genetic polymorphisms on its pharmacokinetics.", "results_summary": "The study predicted no clinically relevant DDI between vericiguat and the UGT1A1 inhibitor atazanavir, with minor AUC and peak plasma concentration increases. It also suggested a modest AUC increase (up to 1.7-fold) in subpopulations with reduced UGT1A1 and UGT1A9 activity due to genetic polymorphisms.", "population_specificity": "Not specified (preclinical and modeling study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "Potential interaction with UGT1A1 inhibitors (e.g., atazanavir) and UGT1A9 inhibitors (e.g., mefenamic acid).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:50.012107+00:00"}
{"study_id": 42802, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the rationale for abstaining from uridine triacetate in cases of 5-FU overdose, questioning its clinical and cost-effectiveness.", "results_summary": "The study reported two cases of 5-FU overdose where uridine triacetate was not used; one patient developed no toxicity, and the other recovered fully with best supportive care. The authors argue that evidence supporting uridine triacetate's effectiveness is inadequate and advocate for further comparative studies.", "population_specificity": "Two elderly female patients (71 and 74 years old) with normal DPYD genotypes who experienced 5-FU overdose.", "effective_dosage": "Not mentioned for uridine triacetate.", "study_duration": "Not mentioned for uridine triacetate.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:50.309446+00:00"}
{"study_id": 42804, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether uridine levels are altered in hepatocellular carcinoma (HCC) tissues and if uridine could be a potential therapeutic target for HCC.", "results_summary": "The study found higher expression of uridine synthesis genes (CAD and DHODH) in HCC tissues compared to non-tumor tissues, with lower uridine content in tumor tissues. Uridine inhibited HCC cell proliferation, invasion, and migration by activating the ferroptosis pathway.", "population_specificity": "Patients with hepatocellular carcinoma (HCC) and corresponding adjacent non-tumor tissues.", "effective_dosage": "High concentrations (specific amounts not detailed in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:50.377925+00:00"}
{"study_id": 42805, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether uridine serves as a metabolic fuel for pancreatic ductal adenocarcinoma (PDA) cells under glucose-deprived conditions and its potential role in tumor progression.", "results_summary": "The study found that uridine, metabolized via UPP1, supports PDA cell survival and proliferation in glucose-restricted conditions by fueling central carbon metabolism and maintaining redox balance. High UPP1 expression correlated with poor patient survival, and UPP1 deletion reduced tumor growth in mouse models.", "population_specificity": "Pancreatic ductal adenocarcinoma (PDA) cell lines and immunocompetent mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:50.727332+00:00"}
{"study_id": 42798, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of uridine (Urd) in improving constipation-related parameters and associated molecular mechanisms in C3-deficient mice.", "results_summary": "Uridine improved stool parameters, gastrointestinal transit, intestinal epithelial barrier function, mucin secretion, water retention, and enteric nervous system regulation in C3-deficient mice.", "population_specificity": "FVB/N-C3em1Hlee/Korl knockout (C3 KO) mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:50.866160+00:00"}
{"study_id": 42803, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether epilepsy patients with variant UGT2B7 -161C>T or UGT1A4*3 c.142 T>G alleles had different lamotrigine exposure compared to wild-type peers.", "results_summary": "The study found no significant difference in dose-adjusted lamotrigine troughs between variant allele carriers and wild-type controls, both in monotherapy and valproate co-treatment groups. Results were consistent across frequentist and Bayesian analyses.", "population_specificity": "Epilepsy patients on lamotrigine monotherapy or lamotrigine + valproate co-treatment, generally healthy and free of interacting drugs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:51.147756+00:00"}
{"study_id": 42801, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether uridine exerts a protective effect against neurotoxin-induced Parkinson's disease (PD) symptoms in rats, specifically through activation of the mitochondrial ATP-dependent potassium (mitoK-ATP) channel.", "results_summary": "Uridine restored neurotoxin-induced behavioral and biochemical changes, including improved motor function, reduced oxidative stress, and preserved mitochondrial integrity. The protective effects were blocked by a mitoK-ATP channel inhibitor, indicating the channel's involvement in uridine's mechanism.", "population_specificity": "Rats with 6-OHDA-induced Parkinson's disease-like symptoms.", "effective_dosage": "30 \u00b5g/kg administered subcutaneously.", "study_duration": "22 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:57.632945+00:00"}
{"study_id": 42806, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to investigate hydrogen abstraction reactions in uridine and guanosine through quantum chemical calculations to determine reaction rate constants.", "results_summary": "The study found that the hydrogen abstraction reaction at the C4' position in uridine's ribofuranose part had a rate constant of 1.62\u00d710^10 L mol^-1s^-1, showing similarity to guanosine despite differing nucleobases.", "population_specificity": "Not applicable (computational study)", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:57.841511+00:00"}
{"study_id": 42810, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate uridine's suitability as an actinometer for validating germicidal photon flux in UVC systems, particularly for water disinfection.", "results_summary": "Uridine's absorption spectrum closely matches microbial inactivation sensitivity in the 240-290 nm range, making it an ideal actinometer for UVC systems. The protocol is effective for both traditional LP mercury lamps and newer UV-LED sources.", "population_specificity": "Not specified (focused on microbial inactivation and photon flux validation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:58.854411+00:00"}
{"study_id": 42808, "supplement_id": 1642, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers sought to characterize accidental and intentional capecitabine exposures and evaluate the use of uridine triacetate as an antidote.", "results_summary": "Uridine triacetate was effective in preventing new or progressive toxicity when administered within 96 hours of capecitabine exposure, with no reported morbidity or mortality. Most cases were managed at home, and only mild latent toxicity was observed in a few cases.", "population_specificity": "Patients with accidental or intentional capecitabine exposures, including acute-on-chronic and acute exposures in capecitabine-na\u00efve individuals.", "effective_dosage": "Not specified", "study_duration": "Administration within 96 hours of exposure", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:59.282221+00:00"}
{"study_id": 42809, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how the aryl hydrocarbon receptor (AHR) regulates UGCG (uridine diphosphate glucose ceramide glucosyltransferase) and its role in ceramide metabolism, keratinocyte differentiation, and epidermal barrier formation.", "results_summary": "The study found that AHR activation increased UGCG RNA levels and ceramide metabolites, enhancing keratinocyte differentiation and barrier function. Tapinarof, an AHR ligand, also upregulated UGCG and related genes, while Ahr-null mice showed reduced Ugcg RNA and ceramide levels.", "population_specificity": "Normal human epidermal keratinocytes and Ahr-null mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:59.403009+00:00"}
{"study_id": 42812, "supplement_id": 1642, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate uridine as a non-toxic, photochemical actinometer for monitoring UV-C reactor designs in the food industry.", "results_summary": "Uridine was found to be as accurate as the standard iodide/iodate actinometry but less precise, requiring more measurements at higher concentrations. A temperature correction was also developed for use between 10\u00b0C and 30\u00b0C.", "population_specificity": "Not specified (laboratory study).", "effective_dosage": "0.2-3.0 mM uridine solution.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:59.613619+00:00"}
{"study_id": 42807, "supplement_id": 1642, "safety_score": "90", "efficacy_score": 95, "quality_score": 80, "study_goal": "The researchers aimed to analyze the clinical features and therapeutic effects of uridine in children with developmental epileptic encephalopathy 50 (DEE50) caused by CAD gene variants.", "results_summary": "Uridine supplementation led to immediate cessation of seizures, significant improvement in anemia and brain atrophy, and normalization of visual evoked potentials in children with DEE50. Most patients achieved long-term seizure freedom, either with uridine monotherapy or combined with anti-seizure medications.", "population_specificity": "6 pediatric patients (3 boys, 3 girls) aged 3.2-5.8 years with uridine-responsive DEE50 caused by CAD gene variants.", "effective_dosage": "100 mg/(kg\u00b7d) orally", "study_duration": "2.4 (2.2, 3.0) years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:00.102563+00:00"}
{"study_id": 42811, "supplement_id": 1642, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to characterize the immunogenicity and expression stability of the uridine analogue 5-ethynyluridine (EU) compared to other uridine analogues (\u03a8 and m\u03a8) for potential use in RNA-based vaccines and therapeutics.", "results_summary": "The study found that EU does not induce immune activation in human macrophages, lacks inflammatory gene expression, and allows prolonged protein expression, though at lower levels than unmodified or other modified uridines. EU showed similar stability and low immunogenicity to \u03a8 and m\u03a8, suggesting its potential for RNA-based applications.", "population_specificity": "Human macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:00.222960+00:00"}
{"study_id": 42814, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether uridine could mitigate mitochondrial dysfunction and skeletal muscle damage in dystrophin-deficient mdx mice, a model for Duchenne muscular dystrophy.", "results_summary": "Uridine reduced fibrosis and improved potassium ion transport and reactive oxygen species production but had no significant effect on muscle strength, inflammation, mitochondrial ultrastructure, or calcium retention capacity. It partially normalized mitophagy-related gene expression but did not resolve OXPHOS dysfunction.", "population_specificity": "Dystrophin-deficient mdx mice (model for Duchenne muscular dystrophy).", "effective_dosage": "30 mg/kg/day, intraperitoneal administration.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:06.806428+00:00"}
{"study_id": 42813, "supplement_id": 1642, "safety_score": "80", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of uridine triacetate (UTA) in treating delayed central nervous system toxicity caused by fluoropyrimidine chemotherapy, even beyond the recommended 96-hour window.", "results_summary": "The study found that UTA rapidly improved clinical status and resolved encephalopathy in a patient with delayed 5-FU toxicity, suggesting its potential efficacy beyond the standard treatment window. Literature review and clinical trial reports supported the use of UTA for life-threatening delayed toxicity on a case-by-case basis.", "population_specificity": "A 64-year-old male with stage IIIA rectal cancer experiencing delayed 5-FU-induced CNS toxicity, later identified as heterozygous for DPD deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:07.549538+00:00"}
{"study_id": 42820, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of uridine on acute respiratory distress syndrome (ARDS) and insulin resistance in a mouse model.", "results_summary": "Uridine treatment significantly attenuated lung histopathological alterations, reduced proinflammatory cytokines, decreased total cells and neutrophils in bronchoalveolar lavage fluid, and improved insulin sensitivity by down-regulating NF-\u03baB signaling and reducing inflammation and oxidative stress.", "population_specificity": "LPS-induced ARDS mice model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.031573+00:00"}
{"study_id": 42816, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of valproic acid, a uridine diphosphate-glucuronosyltransferase inhibitor, on the pharmacokinetics of vixotrigine and its metabolites.", "results_summary": "Valproic acid increased vixotrigine systemic exposure by approximately 70%, decreased M13 metabolite exposure by 50%, and increased M14 and M16 metabolite exposures by approximately 100% and 70%, respectively.", "population_specificity": "30 healthy volunteers", "effective_dosage": "Vixotrigine 150 mg single dose; valproic acid 500 mg three times daily", "study_duration": "22 days", "interactions": "Valproic acid significantly altered vixotrigine pharmacokinetics.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.187729+00:00"}
{"study_id": 42815, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate uridine's antidiabetic potential and its effects on mitochondrial homeostasis in the heart tissue of diabetic mice.", "results_summary": "Uridine normalized plasma glucose and triglyceride levels, improved glucose utilization, prevented mitochondrial and sarcomere abnormalities, and restored mitochondrial biogenesis and mitophagy-related gene expression. It also reduced oxidative phosphorylation dysfunction and lipid peroxidation but did not significantly affect calcium retention capacity or potassium transport.", "population_specificity": "C57BL/6 mice with high-fat diet-streptozotocin-induced diabetes.", "effective_dosage": "30 mg/kg/day, intraperitoneal administration.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.306285+00:00"}
{"study_id": 42817, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether UGT1A6 expression was altered by valproic acid (VPA) and to elucidate the mechanism behind this change, focusing on AhR and Nrf2 pathways.", "results_summary": "VPA treatment increased UGT1A6 mRNA by 7.9-fold in Caco-2 cells, mediated through AhR and Nrf2 pathways but not ERK or JNK pathways. Other HDAC inhibitors similarly induced UGT1A6 mRNA, suggesting HDAC inhibition as the underlying mechanism.", "population_specificity": "Caco-2 cells (human colon adenocarcinoma cell line)", "effective_dosage": "Not specified", "study_duration": "72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.445268+00:00"}
{"study_id": 42818, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of uridine administration on levels of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in rats subjected to REM sleep deprivation.", "results_summary": "Uridine treatment significantly improved the impairment of MMP-3, MMP-9, and TIMP-3 levels and MMP-9 activity caused by REM sleep deprivation, but had no effect on TIMP-1, MMP-2, TIMP-2 levels, or MMP-2 activity.", "population_specificity": "Rats subjected to 96-hour REM sleep deprivation.", "effective_dosage": "1 mmol/kg intraperitoneally twice a day.", "study_duration": "Four days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.664301+00:00"}
{"study_id": 42819, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify UGT1A isoforms involved in SN-38 glucuronidation and assess how genetic variants of these isoforms affect glucuronidation activity in vitro.", "results_summary": "The study found that UGT1A1 and UGT1A6-UGT1A10 exhibit SN-38 glucuronidation activity, with UGT1A1 being the most active. Variants of these isoforms showed reduced glucuronidation activity, suggesting a link between UGT1A variants and irinotecan-induced adverse effects.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:09.636136+00:00"}
{"study_id": 42821, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of uridine in rescuing metabolic and proliferation deficits caused by OXPHOS dysfunction in primary mitochondrial diseases.", "results_summary": "Uridine supplementation, combined with pyruvate, fully rescued the altered metabolic profile and proliferation deficits in fibroblasts from PMD patients and increased survival in a zebrafish rotenone model.", "population_specificity": "Patients with diverse primary mitochondrial diseases (PMD) and a zebrafish model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:14.467551+00:00"}
{"study_id": 42822, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to create new 5-substituted uridine derivatives as potential inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase.", "results_summary": "The study synthesized uridine derivatives with high yields but found no significant inhibitory effect against SARS-CoV-2 in antiviral activity testing.", "population_specificity": "Not specified (in vitro or in vivo context not detailed).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:14.961811+00:00"}
{"study_id": 42824, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to create new 5-substituted uridine derivatives as potential inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase.", "results_summary": "The study synthesized uridine derivatives with high yields, but testing revealed no significant inhibitory effect against SARS-CoV-2.", "population_specificity": "Not specified (in vitro or in vivo testing not detailed).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:15.402872+00:00"}
{"study_id": 42825, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether uridine has anti-aging effects, particularly on intestinal aging, using in vivo and in vitro models.", "results_summary": "Uridine significantly reduced aging markers (Sa-\u03b2-gal-positive cells), inflammation, and oxidative stress in intestinal cells and mice, demonstrating anti-aging effects.", "population_specificity": "In vitro intestinal cell models and in vivo mice models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:15.723126+00:00"}
{"study_id": 42827, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-aging effects of uridine on senescent gastric epithelial cells and its impact on FGF signaling pathways.", "results_summary": "Uridine significantly reduced aging markers (p16, p21), decreased SA-\u03b2-gal-positive cells, lowered inflammation and oxidative stress, and partially restored FGF signaling sensitivity in senescent gastric epithelial cells.", "population_specificity": "Senescent gastric epithelial cells (in vitro model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:16.234421+00:00"}
{"study_id": 42826, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of oral uridine monophosphate (UMP) in treating developmental and epileptic encephalopathy type 50 caused by CAD pathogenic variants.", "results_summary": "Treatment with oral UMP resulted in rapid and remarkable clinical improvement in developmental progress and seizure control in two siblings with CAD pathogenic variants. The study also reviewed and summarized previous literature on similar cases.", "population_specificity": "Two siblings with CAD pathogenic variants presenting with developmental regression and intractable epilepsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:16.474815+00:00"}
{"study_id": 42823, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the regenerative potential and long-term functional effects of Uridine treatment in a rat model of sciatic nerve injury.", "results_summary": "Uridine treatment improved functional recovery (SFI and nerve conduction velocity), enhanced nerve adherence, separability scores, and increased the number of myelinated axons compared to the control group. The results suggest short-term Uridine treatment provides morphological and electrophysiological benefits leading to long-term functional improvement.", "population_specificity": "Male Sprague-Dawley rats with sciatic nerve injury", "effective_dosage": "500 mg/kg, injected intraperitoneally (i.p.) daily", "study_duration": "7 days of treatment, monitored for 12 weeks post-surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:17.901008+00:00"}
{"study_id": 42828, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if uridine, a pyrimidine nucleoside, could rejuvenate aged human stem cells and promote tissue regeneration in vivo.", "results_summary": "The study found that uridine rejuvenated aged human stem cells and promoted regeneration of various tissues in vivo, correlating with active pyrimidine metabolism linked to higher regenerative capacity.", "population_specificity": "Aged human stem cells and in vivo tissue regeneration models (axolotl limb blastema, antler stem cells, primate juvenile and aged tissues).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:18.534725+00:00"}
{"study_id": 42830, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate uridine's potential role in alleviating CCl4-induced liver fibrosis in vitro and in vivo.", "results_summary": "Uridine effectively reduced collagen accumulation, improved liver cell activity, and alleviated CCl4-induced liver injury by down-regulating \u03b1-SMA, collagen type-I, and fibronectin expression.", "population_specificity": "CCl4-induced liver fibrosis models (in vitro and in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:22.572312+00:00"}
{"study_id": 42829, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether uridine could alleviate senescence in chondrocytes and mesenchymal stem cells (MSCs) and relieve osteoarthritis (OA) in in vitro and in vivo models.", "results_summary": "Uridine reduced senescence markers in chondrocytes and MSCs in vitro and alleviated OA symptoms in vivo, demonstrating potential for treating age-related OA.", "population_specificity": "In vitro models of chondrocytes and MSCs, and in vivo OA models (specific organism not stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:23.126929+00:00"}
{"study_id": 42832, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a concise and cost-effective synthesis method for Molnupiravir to improve global accessibility.", "results_summary": "The study reported a novel one-pot synthesis method for Molnupiravir, achieving 62% yield and >99% purity using inexpensive bulk chemicals. This approach reduces purification steps and enhances affordability.", "population_specificity": "Not specified (focused on synthesis methodology, not human trials).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:23.868259+00:00"}
{"study_id": 42834, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of uridine monophosphate (Ur) in a ferret model of inflammation-sensitized hypoxic-ischemic brain injury.", "results_summary": "Uridine monophosphate (Ur) worsened motor outcomes compared to controls and did not provide meaningful neuroprotection. HI animals treated with Ur took longer to complete motor assessments, and Ur failed to mitigate injury-related cortical and white matter damage.", "population_specificity": "Near-term postnatal day 17 ferrets with inflammation-sensitized hypoxic-ischemic brain injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:24.840395+00:00"}
{"study_id": 42835, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of SHP-2 inhibition in osteoarthritis (OA) and its effect on uridine levels and cartilage metabolism.", "results_summary": "SHP-2 inhibition increased uridine levels by reducing uridine phosphorylase 1 expression, contributing to cartilage homeostasis. This mechanism helped maintain the anabolic-catabolic balance in OA.", "population_specificity": "Human OA cartilage samples and mouse models (DMM-induced OA and IL-1\u03b2-stimulated chondrocytes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:26.166868+00:00"}
{"study_id": 42831, "supplement_id": 1642, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical implications of the uridine diphosphate glucuronosyltransferase family 1 member A1*28/*28 genotype in patients receiving sacituzumab govitecan-hziy, particularly regarding neutropenia risk.", "results_summary": "The study found that uridine diphosphate glucuronosyltransferase family 1 member A1*28 homozygous expressors are at increased risk for severe neutropenia with sacituzumab govitecan-hziy, but this did not correlate with higher febrile neutropenia risk. No clear guidance exists for dose adjustments or prophylactic measures in these patients.", "population_specificity": "A 38-year-old pre-menopausal female of South Asian descent with metastatic triple-negative breast cancer.", "effective_dosage": "10 mg/kg/dose on days 1 and 8 of a 21-day cycle (later dose-reduced).", "study_duration": "Until disease progression (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:26.502787+00:00"}
{"study_id": 42833, "supplement_id": 1642, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of oral uridine supplementation in a patient with SLC25A36 deficiency, focusing on improvements in thyroid function, growth, and developmental progress.", "results_summary": "Oral uridine supplementation improved thyroid function, alleviated obstipation, and enhanced growth and developmental progress in the patient. The study suggests uridine as a safe and effective treatment for SLC25A36 deficiency-related symptoms.", "population_specificity": "A 12-year-old patient with SLC25A36 deficiency presenting hypothyroidism, hyperinsulinism, hyperammonemia, chronical obstipation, short stature, and developmental delay.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:26.841403+00:00"}
{"study_id": 42836, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of Uridine diphosphate glucosyltransferases (UGTs), specifically TcUgt86Dg, in the detoxification of Artemisia vulgaris essential oil in Tribolium castaneum.", "results_summary": "The study found that A. vulgaris essential oil significantly induced TcUgt86Dg expression, and silencing this gene increased mortality, indicating its role in detoxification. Higher expression was observed in late adults and specific tissues like the head, antenna, fat body, and accessory gland.", "population_specificity": "Tribolium castaneum (red flour beetle) larvae and adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:27.449638+00:00"}
{"study_id": 42839, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of uridine and guanosine in an asthma model, focusing on their molecular pathways.", "results_summary": "Uridine reduced lung inflammation in OVA-challenged mice, decreasing total cell counts in BALF, cytokines (IL-4, IL-6, IL-13), OVA-specific IgE, and mRNA levels of inflammatory markers. It also suppressed MAPK and NF-\u03baB pathways in vivo and in vitro.", "population_specificity": "OVA-challenged mice (asthma model) and LPS/IFN-\u03b3-induced THP-1 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:32.727310+00:00"}
{"study_id": 42838, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether uridine + pyruvate supplementation could mitigate the off-target effects of mitotoxic antibiotics on immune cell function in patients with asymptomatic bacteriuria or positive sperm culture.", "results_summary": "The study found that uridine + pyruvate supplementation led to a 3.4-fold higher differential lymphocyte count and a 3.7-fold increase in the percentage of dividing T cells compared to the control group, suggesting enhanced immune cell activity during antibiotic treatment.", "population_specificity": "Patients with asymptomatic bacteriuria or positive sperm culture.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:32.741710+00:00"}
{"study_id": 42840, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the relationship between methylglyoxal and uridine diphosphate-induced carotid arterial contraction in rats and whether p38 MAPK was involved in these responses.", "results_summary": "Methylglyoxal enhanced uridine diphosphate-induced contraction in rat carotid arteries, likely through activation of p38 MAPK, protein kinase C, and increased oxidative stress. The augmentation was prevented by N-acetyl-L-cysteine.", "population_specificity": "Rats (isolated carotid arterial rings)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:33.073099+00:00"}
{"study_id": 42837, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate uridine's effect on myocardial ischemic and reperfusion injury and establish a possible mechanism for its cardioprotective action.", "results_summary": "Uridine (30 mg/kg) prevented energy depletion, maintained antioxidant activity, reduced lipid hydroperoxides and diene conjugates, and decreased myocardial necrosis and heart rhythm disturbances. Its effects were limited by the mitoKATP channel blocker 5-hydroxydecanoate, suggesting uridine's cardioprotection may involve mitoKATP activation.", "population_specificity": "Rat models of acute myocardial ischemia and ischemia/reperfusion injury.", "effective_dosage": "30 mg/kg (intravenous)", "study_duration": "60-min ischemia or 30-min ischemia followed by 120-min reperfusion.", "interactions": "5-hydroxydecanoate (mitoKATP channel blocker) limited uridine's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:33.146653+00:00"}
{"study_id": 42842, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-apoptotic and anti-oxidant effects of systemic uridine treatment in a rat model of sciatic nerve injury.", "results_summary": "Uridine at 500 mg/kg significantly reduced apoptosis and exhibited strong anti-oxidant effects, while 100 mg/kg showed modest anti-apoptotic and anti-oxidant benefits compared to controls.", "population_specificity": "Adult male rats with sciatic nerve injury", "effective_dosage": "100 mg/kg and 500 mg/kg, administered intraperitoneally once daily", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:34.495363+00:00"}
{"study_id": 42841, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of UDP-glucose (UDP-G) and the P2Y14R receptor in eosinophil accumulation and airway hyperresponsiveness (AHR) during type 2 inflammation in asthma.", "results_summary": "The study found that UDP-G activates P2Y14R on eosinophils, promoting their migration into the lungs, and that inhibiting P2Y14R reduced eosinophil infiltration and AHR, suggesting potential therapeutic benefits for asthma.", "population_specificity": "The study focused on eosinophils in the context of allergic asthma, but the specific human or animal population is not detailed in the abstract.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:35.168233+00:00"}
{"study_id": 42843, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the anti-HBV and immunostimulatory effects of msiRNAs incorporating unpaired uridine bulges in the passenger strand.", "results_summary": "msiHBx significantly reduced HBsAg and HBV DNA levels while increasing antiviral cytokines (TNF-\u03b1, IFN-\u03b1, IFN-\u03b2) without proinflammatory activation, demonstrating dual RNAi and immunostimulatory activity.", "population_specificity": "HepG2 cells, HepG2.2.15 cells, and peripheral blood mononuclear cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:35.317318+00:00"}
{"study_id": 42844, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how SARS-CoV-2 Nsp15, a uridine-specific endoribonuclease, recognizes uridine and to identify potential inhibitors like Tipiracil for therapeutic intervention against COVID-19.", "results_summary": "The study revealed the structural basis for uridine recognition by Nsp15 and identified Tipiracil as an inhibitor that binds to the uridine pocket, suggesting its potential as an anti-COVID-19 drug. The findings support the development of uracil-based drugs targeting Nsp15.", "population_specificity": "In vitro and structural studies (no human or animal subjects specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:36.335654+00:00"}
{"study_id": 42845, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of uridine supplementation on seizure control, developmental regression, and cerebellar atrophy in siblings with biallelic CAD variants.", "results_summary": "Uridine supplementation led to dramatic improvements in seizure control, development, and cessation of cerebellar atrophy in the younger sibling, while the older sibling showed only modest response. The treatment demonstrated efficacy in halting disease progression in one case.", "population_specificity": "Two siblings with intractable epilepsy, developmental regression, and progressive cerebellar atrophy due to biallelic CAD variants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:41.050971+00:00"}
{"study_id": 42846, "supplement_id": 1642, "safety_score": "85", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical, hematologic, and biochemical effects of uridine triacetate in a patient with hereditary orotic aciduria (HOA) caused by a novel UMPS gene variant.", "results_summary": "The patient showed clinical, hematologic, and biochemical improvement after starting uridine triacetate, indicating its effectiveness in managing HOA symptoms. The study highlights uridine triacetate as a potential treatment for this rare condition.", "population_specificity": "A 17-year-old Emirati girl with hereditary orotic aciduria (HOA) and a novel UMPS gene variant.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:41.304354+00:00"}
{"study_id": 42847, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of uridine, in combination with choline and DHA, in addressing nutritional deficiencies and cognitive decline in individuals with mild cognitive impairment (MCI) due to Alzheimer's disease.", "results_summary": "The study found that a multinutrient intervention including uridine slowed brain atrophy and improved some cognitive measures in individuals with prodromal AD. Uridine was identified as a conditionally essential nutrient in this population, as dietary intake alone could not correct its shortage.", "population_specificity": "Individuals with mild cognitive impairment (MCI) due to Alzheimer's disease (prodromal AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:41.781021+00:00"}
{"study_id": 42848, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of uridine supplementation in treating CAD deficiency, focusing on its impact on epilepsy, anemia, and developmental delay.", "results_summary": "Uridine supplementation led to dramatic improvement in symptoms, including cessation of seizures, resolution of anemia, developmental progress, and prevention of severe manifestations when administered within 2 months of disease onset.", "population_specificity": "Two Chinese infants with CAD deficiency presenting with psychomotor developmental delay, drug-refractory epilepsy, and anemia.", "effective_dosage": "Not specified", "study_duration": "Intervention began within 2 months of disease onset; exact duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:43.234151+00:00"}
{"study_id": 42851, "supplement_id": 1642, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the safety and efficacy of a nucleotide (uridine, cytidine) and vitamin B12 combination versus a B vitamin combination for treating low back pain.", "results_summary": "The nucleotides+B12 group had fewer adverse events, no treatment discontinuations due to AEs, and superior pain reduction at 30 days compared to the B vitamin group, though both groups showed significant pain reduction and functional improvements by 60 days.", "population_specificity": "Adults with low back pain (n=634, split into two groups of 317 each).", "effective_dosage": "Not specified in the abstract.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:43.462133+00:00"}
{"study_id": 42849, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antiviral activity of synthesized uridine glycoconjugates against two strains of TBEV (Hypr and Neudoerfl).", "results_summary": "Four compounds (18-21) showed strong antiviral activity against both TBEV strains, with IC50 values between 15.1 and 3.7 \u03bcM and high selectivity indices due to low cytotoxicity. These compounds may be promising candidates for further development against flaviviruses.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified (IC50 values provided for compounds 18-21).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:43.705617+00:00"}
{"study_id": 42852, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of CPBMF65, a UPP1 inhibitor, on activated hepatic stellate cells and carbon tetrachloride-induced liver fibrosis in mice.", "results_summary": "CPBMF65 reduced cell proliferation and promoted phenotype reversion in vitro, and demonstrated antifibrotic and anti-inflammatory effects in vivo, suggesting potential as a therapeutic agent for liver fibrosis.", "population_specificity": "Mice with carbon tetrachloride-induced liver fibrosis and activated hepatic stellate cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:44.591274+00:00"}
{"study_id": 42850, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate an LC-MS/MS assay for quantifying uridine and DHO in human plasma to support clinical studies on pyrimidine synthesis biomarkers.", "results_summary": "The study successfully validated an LC-MS/MS method for uridine and DHO quantification in human plasma, demonstrating excellent accuracy, precision, and stability under various storage conditions. The assay was applied to human plasma samples to support clinical studies.", "population_specificity": "Human plasma samples (specific population not detailed beyond this).", "effective_dosage": "Not specified (assay validation study, not an intervention trial).", "study_duration": "Not applicable (assay validation study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:45.094209+00:00"}
{"study_id": 42854, "supplement_id": 1642, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to define the genotype and phenotype of CAD deficiency (EIEE-50) and evaluate the safety and efficacy of uridine supplementation as a treatment.", "results_summary": "Uridine supplementation (including uridine monophosphate and uridine triacetate) was safe and led to significant clinical improvement in most of the ten treated patients. The study confirmed CAD deficiency as a progressive disorder with epilepsy, developmental delays, and anemia, and identified milder cases with isolated intellectual disability or neonatal seizures.", "population_specificity": "20 patients with CAD deficiency (EIEE-50), a rare genetic disorder affecting pyrimidine biosynthesis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:50.411250+00:00"}
{"study_id": 42856, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mutation characteristics and clinical relevance of Gilbert syndrome (GS) and Crigler-Najjar syndrome (CNS) in relation to the UGT1A1 gene.", "results_summary": "The study identified 163 mutation sites in the UGT1A1 gene, with specific patterns related to GS and CNS phenotypes, including correlations with exon length, nonsense mutations in CNS type I, and regional aggregation of mutations in Asian populations.", "population_specificity": "Individuals with Gilbert syndrome (GS) and Crigler-Najjar syndrome (CNS).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:50.613287+00:00"}
{"study_id": 42859, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of CPBMF65, a hUP1 inhibitor, on the proliferation of HepG2 hepatocellular carcinoma cells by modulating intracellular uridine levels.", "results_summary": "CPBMF65 reduced HepG2 cell proliferation primarily through cell cycle arrest and senescence, increased intracellular uridine levels, and maintained reduced proliferation during chronic treatment.", "population_specificity": "Human hepatocellular carcinoma cell line (HepG2)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:50.806878+00:00"}
{"study_id": 42858, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a reliable assay to assess the pathogenicity of CAD variants and identify individuals who might benefit from uridine therapy.", "results_summary": "The study identified 11 CAD-deficient individuals who could benefit from uridine therapy, using a cell-based assay to confirm 16 deleterious variants out of 34 tested. The clinical phenotype of these individuals was described, supporting uridine's therapeutic potential.", "population_specificity": "Individuals with biallelic variants in CAD and a phenotype consistent with CAD deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:51.641328+00:00"}
{"study_id": 42853, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a rapid and differential diagnostic method for Acanthamoeba keratitis (AK) using the inosine-uridine preferring nucleoside hydrolase (IPNH) protein from pathogenic Acanthamoeba.", "results_summary": "The study found that the IPNH protein was specific to Acanthamoeba, as it was only detected in lysates of Acanthamoeba origin or its culture media, suggesting its potential as a diagnostic marker for AK. The polyclonal IPNH antibody demonstrated specificity, indicating its utility in rapid and accurate AK diagnosis.", "population_specificity": "Pathogenic Acanthamoeba and clinical isolates, along with non-pathogenic amoeba and other keratitis-causing organisms (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Fusarium solani).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:51.720618+00:00"}
{"study_id": 42860, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the non-oxidative metabolic pathway of ethanol involving uridine diphospho-glucuronosyltransferase (UGT) and sulfotransferase (SULT) enzymes in human liver cells.", "results_summary": "The study demonstrated dose- and time-dependent production of ethylglucuronide (EtG) and ethylsulfate (EtS) in differentiated HepaRG cells and primary human hepatocytes, with UGT1A9 identified as the major UGT involved in ethanol glucuronidation.", "population_specificity": "Human differentiated HepaRG cells and primary human hepatocytes.", "effective_dosage": "Ethanol at 25 or 50 mM.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:53.628613+00:00"}
{"study_id": 42857, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of uridine on reactive oxygen species (ROS) in a neonatal rat model of hyperoxic brain injury.", "results_summary": "Uridine administration prevented hyperoxia-induced decreases in antioxidant enzymes (SOD and GSH-Px) and countered increases in oxidative stress markers (MPO and MDA) in a dose-dependent manner, while also increasing DJ-1 levels. These findings suggest uridine has antioxidative properties that may protect against hyperoxic brain injury.", "population_specificity": "Six-day-old rat pups exposed to hyperoxia (80% oxygen) or normoxia (21% oxygen).", "effective_dosage": "100 mg/kg, 300 mg/kg, or 500 mg/kg, injected intraperitoneally once before hyperoxia exposure.", "study_duration": "48 hours of hyperoxia exposure following a single uridine dose.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:53.916439+00:00"}
{"study_id": 42861, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential for drug-drug interactions (DDIs) of mertansine by assessing its effects on UGT and CYP enzyme activities in human liver microsomes and hepatocytes.", "results_summary": "Mertansine potently inhibited several UGT and CYP enzymes, with dose-dependent suppression of mRNA levels and decreased enzyme activities, suggesting significant DDI potential with substrates of these enzymes.", "population_specificity": "Human liver microsomes and hepatocytes (in vitro study)", "effective_dosage": "1.25-2500 nM (in human hepatocytes)", "study_duration": "48 hours", "interactions": "Potential interactions with substrates of CYP1A2, CYP2B6, CYP2C8/9/19, CYP3A4, UGT1A1, and UGT1A9", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:55.002521+00:00"}
{"study_id": 42863, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of efavirenz monotherapy and UGT1A1 phenotypes on serum bilirubin levels in healthy volunteers.", "results_summary": "Efavirenz significantly reduced total, conjugated, and unconjugated bilirubin levels, with UGT1A1 genotype predicting baseline bilirubin levels but not post-treatment levels. SLCO1B1 genotypes did not influence bilirubin levels.", "population_specificity": "Healthy volunteers", "effective_dosage": "600 mg/day", "study_duration": "17 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:58.674897+00:00"}
{"study_id": 42866, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to highlight the challenges in timely access to uridine triacetate for Greek and European patients experiencing life-threatening fluoropyrimidine toxicity.", "results_summary": "The study reported a case of capecitabine toxicity in a patient with dihydropyrimidine dehydrogenase deficiency, emphasizing the difficulty in accessing uridine triacetate despite its FDA approval for such emergencies. The paper underscores the need for broader availability of this antidote in Europe.", "population_specificity": "66-year-old female colorectal cancer patient with heterozygous dihydropyrimidine dehydrogenase deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:00.044467+00:00"}
{"study_id": 42862, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to elucidate the molecular mechanism by which UCK1 expression is reduced in 5'-AZA-resistant AML cells and explore potential therapeutic strategies to overcome this resistance.", "results_summary": "The study identified that the KLHL2/USP28/ATM axis regulates UCK1 ubiquitination and phosphorylation, influencing 5'-AZA resistance in AML cells. Silencing KLHL2 or overexpressing USP28 sensitized AML cells to 5'-AZA-induced apoptosis in vitro and in vivo.", "population_specificity": "Human AML cell lines and a murine AML model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:00.464415+00:00"}
{"study_id": 42864, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a dose-adjusted combination of regorafenib and FOLFIRI (including irinotecan dose adjustment based on UGT1A1 genotyping) for patients with metastatic colorectal cancer (mCRC).", "results_summary": "The abstract does not provide specific results regarding uridine's effects, as the study focuses on the combination of regorafenib and FOLFIRI, not uridine itself.", "population_specificity": "Previously treated patients with metastatic colorectal cancer (mCRC).", "effective_dosage": "Not mentioned for uridine.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned for uridine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:01.193221+00:00"}
{"study_id": 42868, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of curcumin on the regulation of apoB mRNA cytidine deamination to uridine (C-to-U) editosome components in primary hepatocytes.", "results_summary": "Curcumin significantly increased edited apoB mRNA levels and elevated core editing components (APOBEC-1, ACF, RBM47) while suppressing inhibitory components, suggesting it modulates apoB mRNA editing by coordinating editosome components.", "population_specificity": "Primary mouse hepatocytes", "effective_dosage": "50 \u00b5M curcumin", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:01.943384+00:00"}
{"study_id": 42865, "supplement_id": 1642, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the necessity and optimal dose reduction of irinotecan in UGT1A1 heterozygous patients with lung cancer to minimize adverse effects while maintaining therapeutic efficacy.", "results_summary": "The study found that UGT1A1 heterozygous patients required a 20% dose reduction of irinotecan to maintain safety without compromising therapeutic effect, as evidenced by differences in relative dose intensity (RDI) across genetic groups. No significant difference in time to treatment failure (TTF) was observed between groups.", "population_specificity": "Patients with lung cancer treated with irinotecan at Tokushima University Hospital or Tokushima Municipal Hospital, including wild types, heterozygotes, complex heterozygotes, and homozygotes for UGT1A1 polymorphisms.", "effective_dosage": "Initial dose reduction of irinotecan by approximately 20% for heterozygous patients (specific dosage not provided).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:02.717683+00:00"}
{"study_id": 42867, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of UCK2 as a biomarker for selecting pancreatic cancer patients for RX-3117 treatment and to assess the drug's sensitivity in pancreatic cancer cells.", "results_summary": "High UCK2-mRNA expression correlated with shorter overall survival in pancreatic cancer patients, and UCK2 protein expression was high in most patients, also associated with reduced survival. Pancreatic cancer cells showed sensitivity to RX-3117 at pharmacologically achievable concentrations.", "population_specificity": "Pancreatic cancer patients and pancreatic cancer cell lines (SUIT-2, PANC-1, PDAC-3).", "effective_dosage": "Sensitivity to RX-3117 varied between 0.6 and 11 \u03bcM (specific dosage not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:03.196800+00:00"}
{"study_id": 42869, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the synthesis, biological activity, and clinical potential of 4'-fluoro-2'-C-substituted uridines as inhibitors of HCV NS5B polymerase.", "results_summary": "The uridine analogues showed potent inhibition of HCV NS5B polymerase (IC50 as low as 27 nM) and strong antiviral activity in replicon assays (EC50 as low as 20 nM). A lead compound (AL-335) demonstrated high nucleoside triphosphate levels in human hepatocytes and animal models, with promising results in phase 1 and 2 clinical trials.", "population_specificity": "Primary human hepatocytes, Huh-7 cells, dog liver, and human clinical trial participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:04.277634+00:00"}
{"study_id": 42870, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antiviral properties of uridine derivatives against two strains of tick-borne encephalitis virus (TBEV).", "results_summary": "Four uridine derivatives showed significant anti-TBEV activity with IC50 values ranging from 1.4 to 10.2 \u00b5M and low cytotoxicity, suggesting potential as antiviral therapies. The compounds likely target viral protein maturation by inhibiting glycosylation.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified (IC50 values provided for compounds).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:07.102782+00:00"}
{"study_id": 42872, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of Uck2 in hepatocellular carcinoma (HCC), specifically its expression, clinical significance, and impact on cancer cell migration and invasion.", "results_summary": "The study found that Uck2 is upregulated in HCC tissues and correlates with early recurrence and poor prognosis. Uck2 promotes HCC cell migration and invasion via the Stat3 signaling pathway, and its effects can be neutralized by a Stat3 inhibitor.", "population_specificity": "Patients with hepatocellular carcinoma (HCC) and HCC cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:08.732783+00:00"}
{"study_id": 42871, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether uridine administration could prevent learning and memory impairments caused by REM sleep deprivation in rats.", "results_summary": "Uridine treatment improved learning and memory in sleep-deprived rats and prevented decreases in hippocampal tCaMKII and pCREB ratios, which are associated with long-term potentiation.", "population_specificity": "Sleep-deprived rats", "effective_dosage": "1 mmol/kg uridine, twice daily for four days and once on the fifth day", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:09.196267+00:00"}
{"study_id": 42874, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of UCK2 in cancer cell death and the potential of cytotoxic ribonucleoside analogues targeting UCK2 for cancer treatment.", "results_summary": "The study suggests that UCK2 is linked to apoptosis induction in cancer cells, and cytotoxic ribonucleoside analogues targeting UCK2 show promise in inhibiting cancer development, though direct links to cancer cell death remain unestablished.", "population_specificity": "Cancer cells (in vitro or clinical settings, not specified).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:09.959630+00:00"}
{"study_id": 42873, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the cardiovascular effects of Uridine adenosine tetraphosphate (Up4A), including its role in vascular tone regulation and potential implications in cardiovascular diseases.", "results_summary": "Up4A was found to have varying effects on vascular tone, causing contraction in some rodent arteries and relaxation in others, with an overall vasodilator influence in vivo. It also impacts endothelial angiogenesis, smooth muscle cell proliferation, and vascular calcification, with elevated plasma levels observed in juvenile hypertensive patients.", "population_specificity": "Rodents (rats and mice) and porcine coronary small arteries; human data from juvenile hypertensive patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:10.792977+00:00"}
{"study_id": 43475, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether UAS03, a synthetic analogue of Urolithin A, could mitigate LPS-induced neuroinflammation and associated cognitive impairments, memory deficits, and depression-like behaviors in mice.", "results_summary": "UAS03 significantly improved cognitive and memory functions, reduced depressive symptoms, attenuated neuronal damage, and decreased markers of oxidative stress and pro-inflammatory factors by activating the Nrf2 signaling pathway.", "population_specificity": "Mice with LPS-induced neuroinflammation.", "effective_dosage": "10 and 30 mg/kg doses.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:11.290889+00:00"}
{"study_id": 42875, "supplement_id": 1642, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of U34-enzymes in tumor development, particularly their impact on HIF1\u03b1 mRNA translation and resistance to targeted therapy in melanoma.", "results_summary": "The study found that U34-enzymes are crucial for the survival of glycolytic melanoma cultures and regulate HIF1\u03b1 mRNA translation. Depletion of these enzymes resensitizes resistant melanoma to targeted therapy, suggesting a new therapeutic approach.", "population_specificity": "Glycolytic melanoma cultures (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:11.345064+00:00"}
{"study_id": 43476, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) alleviates rheumatoid arthritis (RA) symptoms by inhibiting inflammatory responses and to explore its potential mechanisms.", "results_summary": "UA significantly reduced arthritis scores, inflammation, pannus formation, and joint destruction in CIA mice. In vitro, UA inhibited LPS-induced migration, proliferation, and NLRP3-mediated pyroptosis in NIH/3T3 cells by modulating NF-\u03baB and AMPK pathways.", "population_specificity": "8-week-old DBA mice with collagen-induced arthritis (CIA) and LPS-stimulated NIH/3T3 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:14.294980+00:00"}
{"study_id": 43477, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) has antimycobacterial effects against Mycobacterium tuberculosis (Mtb) and to elucidate its underlying mechanism.", "results_summary": "UroA significantly inhibited Mtb growth in macrophages and mice, activated autophagy via the protein kinase B-Forkhead box protein O1 pathway, and synergistically enhanced the effect of isoniazid (INH) against drug-resistant Mtb.", "population_specificity": "Macrophages and mice infected with Mycobacterium tuberculosis (Mtb).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with isoniazid (INH) noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:15.917415+00:00"}
{"study_id": 43479, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if Urolithin A (UrA) could enhance autophagy and mitophagy in CAR T cells, improving their persistence and anti-tumor efficacy.", "results_summary": "Urolithin A synergized with semaglutide to activate autophagy and mitophagy, enhancing mitochondrial metabolism in CAR T cells, increasing memory T cells, and improving anti-tumor activity in vitro and in xenograft models.", "population_specificity": "CAR T cells in vitro and xenograft models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:16.536610+00:00"}
{"study_id": 43480, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could improve cardiovascular function by addressing mitochondrial quality dysfunctions in aging and heart failure models, as well as its potential to reduce CVD risk markers in healthy older adults.", "results_summary": "UA reduced systolic and diastolic cardiac dysfunction in preclinical models of aging and heart failure, improved mitochondrial ultrastructure and mitophagy, and significantly lowered plasma ceramides (a CVD risk predictor) in healthy older adults after 4 months of supplementation.", "population_specificity": "Human cardiomyocytes (preclinical), healthy older adults (human trial).", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 months (human trial).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:18.489504+00:00"}
{"study_id": 43481, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) influences multiple myeloma (MM) progression and treatment, including its cytotoxic effects and potential synergy with bortezomib.", "results_summary": "UroA demonstrated cytotoxicity against MM cell lines, inhibited primary MM cell proliferation in vitro and in vivo, and improved survival in a xenograft model. Combination therapy with bortezomib showed synergistic effects, even in resistant cases.", "population_specificity": "45 patients with active MM or premalignant disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with bortezomib noted; no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:18.968240+00:00"}
{"study_id": 43482, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate cognitive deficits and neuroinflammation in a female rat model of schizophrenia.", "results_summary": "UA treatment reversed MK801-induced cognitive deficits and neuroinflammation in female rats by inhibiting the NLRP3 signaling pathway and microglial activation. The study suggests UA may be effective as a dietary supplement for preventing cognitive impairments in schizophrenia.", "population_specificity": "Female Sprague Dawley rats (8-week-old) with MK801-induced schizophrenia-like behaviors.", "effective_dosage": "150 mg/kg administered via oral gavage.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:19.882816+00:00"}
{"study_id": 43483, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to explore the impact of Urolithin A on insulin and anabolic sensitivity in human skeletal muscle cells.", "results_summary": "Urolithin A at 50 \u00b5M enhanced basal- and insulin-stimulated glucose uptake by 21% and 24%, respectively, upregulated GLUT4 expression, and reduced myostatin expression by 14%, but did not affect amino acid-stimulated protein synthesis.", "population_specificity": "Primary human myogenic cultures derived from skeletal muscle biopsies of eight healthy adults.", "effective_dosage": "0.002, 1, and 50 \u00b5M for 24 hours.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:20.126911+00:00"}
{"study_id": 43484, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop and validate an ultrasensitive LC-MS/MS method for the simultaneous detection and quantification of urolithin A (UA) and cyclosporine A (CsA) in various mammalian plasma samples.", "results_summary": "The study successfully developed a highly sensitive and precise LC-MS/MS method for quantifying UA and CsA, achieving a limit of quantification (LOQ) of 0.5-125 ng/mL for UA with excellent linearity (R2 \u2265 0.999) and stability. The method was validated across multiple mammal models and applied to canine samples, demonstrating its clinical utility for precise dose adjustments.", "population_specificity": "Various mammalian plasma samples (human, mouse, rat, feline, canine, bovine).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:21.181190+00:00"}
{"study_id": 43485, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (URA) could mitigate ferroptosis and apoptosis in hyperlipidemic tenocytes and elucidate its molecular mechanisms for treating tendinopathy.", "results_summary": "URA treatment blocked ferroptosis and apoptosis, improved oxidative stress, reversed ECM marker changes, and enhanced antioxidant enzyme activities in palmitate-treated tenocytes, mediated through PPAR\u03b4/ALDH2 signaling.", "population_specificity": "Human primary tenocytes treated with palmitate to model hyperlipidemic conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:22.763520+00:00"}
{"study_id": 43487, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore whether Urolithin A (UA) could alleviate doxorubicin (Dox)-induced cardiotoxicity and the mechanisms involved, particularly focusing on mitophagy and mitochondrial integrity.", "results_summary": "UA alleviated Dox-induced cardiac dysfunction, partially reduced apoptosis, and improved mitochondrial function by restoring mitophagy, evidenced by upregulated mitophagy-related proteins (p62, LC3, PINK1, Parkin) and inhibition of PINK1 degradation via Ambra1-LONP1 interaction.", "population_specificity": "Mice and H9C2 cells (a rat cardiomyocyte cell line).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:25.901125+00:00"}
{"study_id": 43486, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate acute inflammation and promote mitochondrial health following spinal cord injury (SCI) by inhibiting NLRP3 inflammasome activation and pyroptosis.", "results_summary": "UA treatment inhibited NLRP3 inflammasome activation, reduced pyroptosis, restored mitochondrial activity, and promoted mitophagy in both an SCI mouse model and LPS-primed BV2 cells. These effects were partially reversed by the autophagy inhibitor 3-MA, suggesting UA's protective role is linked to mitophagy enhancement.", "population_specificity": "Mice with impact-induced spinal cord injury and LPS-primed BV2 microglial cells.", "effective_dosage": "50 mg/kg/day (mice), 10 \u03bcM (BV2 cells)", "study_duration": "8 weeks (mice)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:26.318664+00:00"}
{"study_id": 43490, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could protect against myocardial ischemia-reperfusion (MIR) injury by attenuating oxidative stress and ferroptosis, and to explore its potential mechanisms of action.", "results_summary": "UA protected the heart from ischemia-reperfusion injury, improved cardiac function, reduced oxidative stress and mitochondrial damage, and inhibited ferroptosis. These effects were mediated through the Nrf2 signaling pathway, as Nrf2 inhibition abolished UA's protective effects.", "population_specificity": "In vitro and in vivo models of myocardial ischemia-reperfusion injury (specific species not mentioned in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:28.238220+00:00"}
{"study_id": 43491, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the potential effectiveness of Urolithin A (UA) in non-small-cell lung cancer (NSCLC) therapy and uncover its underlying mechanisms.", "results_summary": "UA inhibited NSCLC cell proliferation, migration, and invasion by accelerating the degradation of TMSB10 via the autophagy-lysosome pathway. Reduced TMSB10 levels disrupted F-actin formation, impairing cell migration in A549 cells.", "population_specificity": "NSCLC cell lines (A549 cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:28.555786+00:00"}
{"study_id": 43489, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether inflammation-targeting nanoparticles (ITNPs) loaded with urolithin A (UroA) or its synthetic analogue UAS03 could improve therapeutic outcomes in inflammatory bowel disease (IBD) by enabling targeted drug delivery to inflamed intestinal regions.", "results_summary": "The study found that ITNPs loaded with UroA or UAS03 significantly attenuated colitis in pre-clinical models, demonstrating improved therapeutic efficacy at lower doses and reduced frequency compared to free drug administration. The targeted approach enhanced drug delivery to inflamed tissues, suggesting potential for better IBD treatment with minimized systemic side effects.", "population_specificity": "Pre-clinical models (human and mouse intestines).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:28.649360+00:00"}
{"study_id": 43493, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the therapeutic effect and mechanism of Urolithin A (UA) on ALS exacerbated by copper exposure in SOD1G93A transgenic mice.", "results_summary": "UA administration activated mitophagy, improved mitochondrial dysfunction, reduced neuroinflammation, and alleviated muscle atrophy and motor dysfunction in SOD1G93A mice with copper exposure. It also modulated abnormal changes in mitochondria-related biological processes, increasing ATP levels and decreasing MDA levels.", "population_specificity": "SOD1G93A transgenic mice with copper exposure", "effective_dosage": "50 mg/kg/day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:30.354174+00:00"}
{"study_id": 43495, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate pulmonary hypertension (PH) by inhibiting pyroptosis in pulmonary arterial smooth muscle cells (PASMCs).", "results_summary": "UA treatment suppressed PH progression by alleviating pulmonary remodeling and inhibiting PASMC pyroptosis via the AMPK/NF-\u03baB/NLRP3 pathway. Hypoxia-induced upregulation of pyroptosis-related genes was reversed with UA administration.", "population_specificity": "Mice exposed to hypoxia to induce PH.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:31.365169+00:00"}
{"study_id": 43496, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the relationship between Urolithin A (UA) and circadian rhythm regulation in intestinal barrier function and its potential therapeutic effects on inflammation-related conditions like IBD.", "results_summary": "UA influenced the expression rhythm of clock genes (BMAL1, PER2) and tight junctions (OCLN, TJP1, CLND1) in intestinal epithelial cells, improved fecal IgA concentrations and tight junction expression in a DSS-induced colitis model, and involved the Nrf2-SIRT1 signaling pathway. UA also impacted the central clock in the SCN.", "population_specificity": "Female C57BL/6 mice (DSS-induced colitis model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:35.638618+00:00"}
{"study_id": 43497, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of Urolithin A (UA) on RSV-induced lung infection in neonatal mice and explore its underlying mechanisms, focusing on the miR-136-mediated Sirt1 signaling pathway.", "results_summary": "UA dose-dependently alleviated RSV-induced lung pathologies, reduced inflammatory cells and factors, decreased apoptosis, and modulated autophagy markers in neonatal mice and BEAS-2B cells. The study confirmed UA's mechanism involves the miR-136-Sirt1 pathway.", "population_specificity": "Neonatal Babl/c mice (5-7 days old) and RSV-infected BEAS-2B cells.", "effective_dosage": "2.5, 5, and 10 mg/kg (mice); 2.5, 5, and 10 \u00b5mol/L (cells).", "study_duration": "2 weeks (mice).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:36.897210+00:00"}
{"study_id": 43499, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the potential geroprotective effects of Urolithin A in humans, focusing on anti-inflammatory, mitochondrial, and muscle-related outcomes.", "results_summary": "Urolithin A showed dose-dependent anti-inflammatory effects, upregulated mitochondrial genes and autophagy markers, and improved muscle strength and endurance, but did not affect mitochondrial ATP production, biogenesis, gut microbiota, or cardiovascular outcomes. Adverse events were mild or moderate and unrelated.", "population_specificity": "250 healthy individuals", "effective_dosage": "10-1000 mg/day", "study_duration": "28 days to 4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:37.045069+00:00"}
{"study_id": 43498, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effect of Urolithin A (UroA) on intrahepatic vascular resistance (IHVR) and cirrhotic portal hypertension (CPH) in mice models.", "results_summary": "UroA deficiency was linked to CPH severity in both patients and mice. UroA supplementation or administration of UroA-producing bacteria (Lactobacillus murinus) effectively reduced IHVR and ameliorated CPH by inhibiting hepatic stellate cell glutaminolysis.", "population_specificity": "Mice with induced liver fibrosis and CPH, and human patients with CPH.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:37.177037+00:00"}
{"study_id": 43500, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A enhances mucin production in the colon and protects intestinal barrier function via Nrf2 and AhR signaling pathways.", "results_summary": "Urolithin A thickened colonic mucus by increasing mucin 2 expression through Nrf2 and AhR pathways, reduced mucosal permeability, alleviated colitis, and boosted short-chain fatty acid-producing bacteria and propionic acid levels. In vitro studies confirmed Uro A's mucus-promoting effects via the same pathways.", "population_specificity": "Wild-type mice, Nrf2-deficient mice, and wild-type mice treated with an AhR antagonist, plus LS174T mucin-producing cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:38.093898+00:00"}
{"study_id": 43501, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could provide neuroprotective benefits and preserve visual function in a model of age-related macular degeneration (AMD) induced by sodium iodate (SI).", "results_summary": "UA alleviated neurodegeneration, preserved visual function, restored autophagic flux, and triggered PINK1/Parkin-dependent mitophagy in SI-treated mice. It also resolved severe proteostasis defects and restored lysophagy via the SQSTM1/p62 pathway.", "population_specificity": "SI-treated mice (in vivo), with additional in vitro and ex vivo models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:39.094580+00:00"}
{"study_id": 43502, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could alleviate alcohol-related liver disease (ALD) by modulating the gut-microbiota-liver axis and its underlying mechanisms.", "results_summary": "UA effectively ameliorated alcohol-induced metabolic disorders and hepatic ER stress via a gut-microbiota-liver axis mediated by MUP1, restored dysbiosis by enriching beneficial bacteria (B. sartorii, P. distasonis, A. muciniphila), and increased propionic acid production, mimicking UA's protective effects.", "population_specificity": "Mice with alcohol-induced liver disease.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:40.472950+00:00"}
{"study_id": 43492, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could inhibit or reverse TGF-\u03b21 and high glucose-induced podocyte dysfunction, a key factor in diabetic kidney disease.", "results_summary": "UA inhibited TGF-\u03b21 and high glucose-induced epithelial-to-mesenchymal transition (EMT) effects in podocytes, including reduced nephrin expression, increased motility, and upregulation of b3 integrin and fibronectin. UA also lowered TGF-\u03b2 receptor expression and Smad2 activation, suggesting potential therapeutic benefits for diabetic podocytopathies.", "population_specificity": "In vitro cultured podocytes under normal (5.5 mM) and high glucose (25 mM) conditions.", "effective_dosage": "Not specified", "study_duration": "24-hour treatment following a 7-day glucose incubation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:40.476022+00:00"}
{"study_id": 43503, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether urolithin A inhibits oral squamous cell carcinoma (OSCC) growth and induces apoptosis and autophagy in vitro and in vivo.", "results_summary": "Urolithin A induced cell death in OSCC via endoplasmic reticulum stress and inhibition of AKT/mTOR/ERK signaling, reducing tumor size in mouse models. It showed potential as an anticancer agent by suppressing proliferation and invasion.", "population_specificity": "Oral squamous cell carcinoma (OSCC) cell lines and in vivo mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:45.144987+00:00"}
{"study_id": 43505, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the therapeutic effects of pomegranate-derived extracellular vesicles (P-EVs) and Urolithin A (UA) in treating severe acute pancreatitis (SAP) and to explore UA's mechanisms of action.", "results_summary": "UA showed superior therapeutic effects compared to P-EVs, improving pancreatic inflammation and peripheral blood circulation in SAP mice. The study revealed that UA's mechanism involves regulating ER-mitochondrial calcium channels and reducing pancreatic tissue necroptosis.", "population_specificity": "SAP mice and in vitro mouse pancreatic organoids and acinar cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:45.736138+00:00"}
{"study_id": 43507, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticancer properties of Urolithin A (UA) on colorectal cancer (CRC) cell lines, focusing on its effects on cell growth, migration, and metastasis.", "results_summary": "UA suppressed CRC cell growth in a dose- and time-dependent manner, significantly reduced cell migration and colony formation, and inhibited metastasis by lowering MMP1 and MMP2 expression while increasing TIMP1 levels.", "population_specificity": "Colon cancer cell lines (HT29, SW480, SW620)", "effective_dosage": "100 \u00b5M", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:46.181578+00:00"}
{"study_id": 43504, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could restore abnormal protein networks in the aBLA and improve social ability in 5xFAD mice with A\u03b2 accumulation.", "results_summary": "UA administration restored the abnormal protein network in the aBLA, attenuated disorganized firing in the aBLA-vCA1 pathway, and improved social ability in 5xFAD mice.", "population_specificity": "5xFAD mice (a model of Alzheimer's disease with amyloid-\u03b2 accumulation).", "effective_dosage": "Not specified", "study_duration": "One month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:46.324068+00:00"}
{"study_id": 43506, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the long-term effects and mechanisms of Urolithin A (UA) on Alzheimer's disease (AD) pathology, including cognitive function, amyloid beta and tau pathologies, and lysosomal function.", "results_summary": "Long-term UA treatment improved learning, memory, and olfactory function in AD mice, reduced amyloid beta and tau pathologies, enhanced long-term potentiation, and restored lysosomal function by regulating cathepsin Z.", "population_specificity": "Transgenic mouse models of Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Long-term (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:46.667585+00:00"}
{"study_id": 43508, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how Urolithin A affects tumor-associated macrophages and tumor cells to inhibit breast cancer progression.", "results_summary": "Urolithin A inhibited harmful inflammatory factors (IL-6, TNF-\u03b1) in breast cancer cells and tumor-associated macrophages, improving the tumor microenvironment and delaying tumor progression. It induced TFEB nuclear localization, enhancing mitophagy-lysosomal pathway activity and reducing inflammation caused by damaged mitochondria.", "population_specificity": "Breast cancer models (in vivo and in vitro).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:48.968492+00:00"}
{"study_id": 43509, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) could protect against bupivacaine (BUP)-induced neurotoxicity in SH-SY5Y cells and the underlying mechanisms involved.", "results_summary": "UroA effectively counteracted BUP-induced neurotoxicity by reducing apoptosis, oxidative stress, and inflammatory responses in SH-SY5Y cells, mediated through SIRT1-dependent activation of PI3K/AKT signaling. These protective effects were reversed when SIRT1 or PI3K/AKT signaling was inhibited.", "population_specificity": "SH-SY5Y human neuroblastoma cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:49.990804+00:00"}
{"study_id": 43510, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could prevent microglial activation and neuroinflammation induced by a viral mimetic (poly I:C) in a neuron-astrocyte-microglia co-culture system.", "results_summary": "UA significantly prevented poly I:C-induced microglial activation, restored microglial morphology, reduced pro-inflammatory mediators (CCL2, TNF-\u03b1, IL-1\u03b2), and showed a trend toward attenuating ROS production.", "population_specificity": "In vitro triple co-culture system of neurons, astrocytes, and microglial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:50.629046+00:00"}
{"study_id": 43511, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the therapeutic effects and underlying mechanisms of Urolithin A (UroA) in gastric cancer (GC), focusing on its anti-tumor properties and impact on autophagy and gut microbiota.", "results_summary": "UroA suppressed tumor progression in GC by activating autophagy, which in turn inhibited the Warburg effect and promoted apoptosis. Additionally, UroA modulated gut microbiota composition by increasing probiotics and decreasing pathogenic bacteria.", "population_specificity": "Gastric cancer cell lines and a xenograft mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:33:53.394923+00:00"}
{"study_id": 116681, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of dietary interventions, including Vitamin D supplementation, in improving atopic dermatitis (AD) severity and symptoms.", "results_summary": "The study found that Vitamin D supplementation was effective in improving AD severity and subjective symptoms, particularly in adult populations, though gaps in long-term and multidisciplinary approaches were noted.", "population_specificity": "Adults with atopic dermatitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:00.527549+00:00"}
{"study_id": 116675, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to highlight the prevalence and importance of micronutrient deficiencies, including Vitamin D, in school-age and adolescent individuals.", "results_summary": "The study confirms that Vitamin D deficiency is common in pediatric populations and can be corrected efficiently through interventions like food fortification and supplementation, resulting in clinical benefits.", "population_specificity": "School-age and adolescent individuals, particularly those with imbalanced diets or picky eating behaviors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:00.605737+00:00"}
{"study_id": 116682, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether Vitamin D, with or without omega-3 fatty acids, could reduce the incidence of autoimmune diseases, including rheumatoid arthritis (RA).", "results_summary": "The study found that Vitamin D, with or without omega-3 fatty acids, reduced the incidence of autoimmune diseases, including RA. However, the abstract does not provide detailed statistical significance or effect size for Vitamin D alone.", "population_specificity": "Individuals at risk for future rheumatoid arthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:00.945671+00:00"}
{"study_id": 116677, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of calcium, alone and combined with Vitamin D, in managing colorectal cancer and overall health, focusing on the calcium-sensing receptor (CaSR) pathway.", "results_summary": "The study found that calcium, especially when combined with Vitamin D, shows promise in managing cancer growth, particularly in colorectal cancer, and highlights CaSR as a potential biomarker and therapeutic target.", "population_specificity": "Not specified (general focus on colorectal cancer management)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:01.078927+00:00"}
{"study_id": 116678, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the immunomodulatory potential of Vitamin D and zinc in enhancing immune defenses and combating viral infections, particularly in animals.", "results_summary": "The study found that Vitamin D and zinc exhibit antiviral, anti-inflammatory, antioxidative, and immunomodulatory properties, which are crucial for innate and adaptive immunity. Deficiencies in these micronutrients were linked to impaired immune responses and increased susceptibility to viral infections.", "population_specificity": "Animals (specific species not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:01.361719+00:00"}
{"study_id": 116679, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether vitamin D supplementation improves muscle weakness in adults with alcohol use disorder and vitamin D deficiency.", "results_summary": "Vitamin D supplementation improved quadriceps maximum voluntary contractions (qMVC) and increased serum 25(OH)D concentrations in participants with deficiency, though no significant difference was found between high-dose (VIDIO) and standard-dose (CAU) strategies for muscle health.", "population_specificity": "Community-dwelling adults with alcohol use disorder (mean age 51 years, median alcohol consumption of 52 drinks per week).", "effective_dosage": "VIDIO group: 50,000-100,000 IU cholecalciferol bimonthly; CAU group: 800 IU cholecalciferol daily with 500 mg calcium carbonate.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:03.222070+00:00"}
{"study_id": 116676, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy of vitamin D2 supplementation on serum vitamin D levels through a dose-response meta-analysis of randomized controlled trials.", "results_summary": "Vitamin D2 supplementation significantly increased total vitamin D, 25(OH)D2, and 1,25(OH)D concentrations but decreased 25(OH)D3 levels. Greater effects were observed with doses >2000 IU/day, shorter durations (\u226412 weeks), older participants (\u226560 years), and those with baseline 25(OH)D <20 ng/mL.", "population_specificity": "Participants across various ages, with subgroup analysis highlighting those aged \u226560 years and individuals with baseline 25(OH)D <20 ng/mL.", "effective_dosage": "Doses varied, with >2000 IU/day showing more significant effects.", "study_duration": "Interventions ranged, with \u226412 weeks showing stronger results.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:03.424396+00:00"}
{"study_id": 116680, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to assess the benefit of a combination of three probiotic strains plus vitamin D in patients with diarrhea-predominant IBS (IBS-D) or IBS with mixed bowel movements (IBS-M).", "results_summary": "The study found that the combination of probiotics and vitamin D led to a significant responder rate (62.9%) and a mean decrease in IBS-SSS scores, correlating with improvements in quality of life, anxiety, depression, and gut-related anxiety.", "population_specificity": "Adult patients with IBS-D or IBS-M (Rome IV criteria) followed by private-practice gastroenterologists (mean age 51.2\u00b115.4 years; 73.2% women).", "effective_dosage": "Not specified for vitamin D (probiotic dosage: one sachet daily containing 3\u00d710^9 CFU).", "study_duration": "42 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:04.176599+00:00"}
{"study_id": 116684, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Vitamin D supplementation in managing cancer treatment-induced bone loss (CTBL) and osteoporosis.", "results_summary": "The abstract mentions that lifestyle management, including Vitamin D supplementation, is recommended for CTBL, but the supporting evidence is limited. No specific outcomes or effects of Vitamin D are detailed.", "population_specificity": "Patients with cancer treatment-induced bone loss (CTBL), particularly those at heightened risk for osteoporosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:08.720288+00:00"}
{"study_id": 116688, "supplement_id": 1663, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the therapeutic effects of Metformin combined with vitamin D in patients with polycystic ovary syndrome (PCOS).", "results_summary": "The meta-analysis found that Metformin combined with vitamin D significantly reduced insulin resistance, BMI, and testosterone levels, increased serum vitamin D levels, and improved menstrual cycle regulation in PCOS patients.", "population_specificity": "Women of childbearing age with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:34:08.878696+00:00"}
